|
sig_a358924bc3b4
|
evt_789ee560b6a9
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1163792/0001193125-26-161605.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1163792/0001193125-26-161605.txt","company":"WESTERN ASSET PREMIER BOND FUND","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1163792/0001193125-26-161605.txt","article_chars":4999,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_cac309539fa15baf","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1163792/0001193125-26-161605.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:15:21.126926+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"Western Asset Premier Bond Fund","final_url":"https://www.sec.gov/Archives/edgar/data/1163792/0001193125-26-161605.txt","html_truncated":true,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1163792/0001193125-26-161605.txt","source_event_id":"evt_adc33c253fab","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"DEF 14A","fp":"71a2ae18b2ec8a3e","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-17","2026-05-21","2026-03-27"],"entities":[{"asset_class":"closed-end fund (implied by proxy materials context)","name":"Western Asset Premier Bond Fund","relevance":"high","symbol":"WEA","type":"issuer"}],"event_type":"listing","information_gaps":["What specifically changed vs prior known state is not provided in the signal (no prior filing comparison text included).","The filing\u2019s amendment number is shown as blank in the provided text (\"Amendment No. \").","No financial guidance or financial implications are disclosed in the provided excerpt beyond meeting/proxy mechanics.","No details on trustee nominees, compensation, or other agenda items beyond trustee re-election are included in the provided text."],"key_facts":["The filing is a Schedule 14A proxy statement in definitive form (DEF 14A).","Issuer: Western Asset Premier Bond Fund (NYSE \u2013 WEA).","Annual Meeting scheduled for Thursday, May 21, 2026 at 10:00 a.m. Eastern Time.","Meeting location: One Madison Avenue, 17th Floor, New York, New York 10010.","Record date (close of business): March 27, 2026.","Shareholders will be asked to consider the re-election of ten Trustees (Nominees).","The proxy statement is furnished in connection with solicitation by the Board of Trustees.","The proxy statement availability link provided: https://www.proxy-direct.com/fnk-35059.","The proxy is solicited on behalf of the Board of Trustees; voting methods are referenced (telephone, internet, mail).","If meeting time/location/format changes, updates will be provided via press release posted on the issuer\u2019s website and filed with the SEC via EDGAR."],"numeric_claims":[{"label":"Annual meeting date","value":"2026-05-21"},{"label":"Annual meeting time (ET)","value":"10:00 a.m."},{"label":"Record date (close of business)","value":"2026-03-27"},{"label":"Number of trustees to be re-elected","value":"10"}],"primary_claim":"Western Asset Premier Bond Fund (NYSE: WEA) filed a DEF 14A proxy statement for an annual meeting scheduled for May 21, 2026 at 10:00 a.m. Eastern Time.","relevance_score":0.55,"sentiment":"neutral","source_quality":"high","summary":"Western Asset Premier Bond Fund filed a definitive proxy statement on Schedule 14A (DEF 14A) for its annual shareholders meeting. The filing sets the meeting date/time and record date and describes trustee re-election items.","topics":["SEC filing","proxy statement","annual meeting","board of trustees","shareholder voting","record date"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form DEF 14A \u00b7 WESTERN ASSET PREMIER BOND FUND \u00b7 Filed 20260417","ticker":"WEA","tickers":["WEA"],"title":"WEA filed DEF 14A","url":"https://www.sec.gov/Archives/edgar/data/1163792/0001193125-26-161605.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_adc33c253 {"_evidence_event_ids":["evt_adc33c253fab"]}...
|
signal_enriched:discovery_sec_filing_delta:305401e signal_enriched:discovery_sec_filing_delta:305401e3bdbaf5e2...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_7e6854b38922
|
evt_8c7e6ad2f6f5
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/929008/0001193125-26-159707.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/929008/0001193125-26-159707.txt","company":"WESCO INTERNATIONAL INC","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/929008/0001193125-26-159707.txt","article_chars":3269,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_a002f72689b231cd","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/929008/0001193125-26-159707.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:15:36.980426+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"DEFA14A","final_url":"https://www.sec.gov/Archives/edgar/data/929008/0001193125-26-159707.txt","html_truncated":true,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/929008/0001193125-26-159707.txt","source_event_id":"evt_1ade6b479276","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"DEFA14A","fp":"7d13d662dcb0db31","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-17","May 14, 2026","May 25, 2026","May 27, 2026","May 28, 2026"],"entities":[{"asset_class":"equity","name":"WESCO INTERNATIONAL, INC.","relevance":"high","symbol":"","type":"issuer"},{"asset_class":"other","name":"PricewaterhouseCoopers LLP","relevance":"medium","symbol":"","type":"auditor"}],"event_type":"listing","information_gaps":["What specifically changed versus the prior known state is not provided in the text (no prior filing comparison content included).","The \u201cAmendment No.\u201d field is blank in the provided text.","No financial guidance or financial implications are disclosed in the provided excerpt beyond advisory compensation and auditor ratification.","No details are provided about the solicitation context beyond the voting notice and proposal overview (e.g., rationale, contested matters, or changes to nominees/terms)."],"key_facts":["The document is a Schedule 14A proxy statement (Amendment No. not specified in the provided text).","Form type is DEFA14A and is marked as \u201cDefinitive Additional Materials.\u201d","WESCO INTERNATIONAL, INC. annual meeting is scheduled for May 28, 2026.","Voting deadline for shares held in general is May 27, 2026 at 11:59 PM EDT.","Voting deadline for shares held in a Plan is May 25, 2026 at 11:59 PM EDT.","Board recommends voting on Item 1: elect ten directors for a one-year term expiring in 2027.","Director nominees listed: John J. Engel; Glynis A. Bryan; Michael L. Carter; Anne M. Cooney; Matthew J. Espe; Sundaram Nagarajan; James L. Singleton; Easwaran Sundaram; Laura K. Thompson; David C. Wajsgras.","Item 2: approve, on an advisory basis, the compensation of the Company\u2019s named executive officers.","Item 3: ratify the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the year ending December 31, 2026.","The filing states \u201cNo fee required.\u201d","The notice indicates proxy materials availability and provides methods to view or request paper/email copies (ProxyVote.com, phone 1-800-579-1639, or email sendmaterial@proxyvote.com) with a request deadline of May 14, 2026."],"numeric_claims":[{"label":"Annual meeting date","value":"May 28, 2026"},{"label":"General vote deadline","value":"May 27, 2026 11:59 PM EDT"},{"label":"Plan vote deadline","value":"May 25, 2026 11:59 PM EDT"},{"label":"Proxy materials request deadline","value":"May 14, 2026"},{"label":"Auditor year ending","value":"December 31, 2026"},{"label":"Number of directors to elect","value":"10"}],"primary_claim":"WESCO INTERNATIONAL, INC. filed Form DEFA14A as definitive additional proxy materials for its 2026 annual meeting scheduled for May 28, 2026.","relevance_score":0.55,"sentiment":"neutral","source_quality":"high","summary":"WESCO INTERNATIONAL, INC. filed a definitive additional proxy-related filing (DEFA14A) for its 2026 annual meeting, providing notice and an overview of proposals and voting logistics. The filing includes director election, advisory executive compensation, and ratification of the independent auditor for the year ending December 31, 2026.","topics":["SEC filing","proxy materials","annual meeting","director election","executive compensation (advisory)","independent auditor ratification","shareholder voting logistics"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form DEFA14A \u00b7 WESCO INTERNATIONAL INC \u00b7 Filed 20260417","ticker":"WCC","tickers":["WCC"],"title":"WCC filed DEFA14A","url":"https://www.sec.gov/Archives/edgar/data/929008/0001193125-26-159707.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_1ade6b479 {"_evidence_event_ids":["evt_1ade6b479276"]}...
|
signal_enriched:discovery_sec_filing_delta:8cce100 signal_enriched:discovery_sec_filing_delta:8cce100fe3e4f674...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_06373c1b3ad7
|
evt_c8d24c85f46d
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1645155/0001493152-26-017774.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1645155/0001493152-26-017774.txt","company":"Webstar Technology Group Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1645155/0001493152-26-017774.txt","article_chars":4999,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_ee41a001bc650fe7","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1645155/0001493152-26-017774.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:15:42.044185+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1645155/0001493152-26-017774.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1645155/0001493152-26-017774.txt","source_event_id":"evt_6f7c060ec47f","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"8-K","fp":"d091bf47ec7ba765","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.7,"dates_mentioned":["2026-04-17","2026-04-18"],"entities":[{"asset_class":"equity","name":"Webstar Technology Group Inc.","relevance":"high","symbol":"WBSR","type":"issuer"}],"event_type":"other","information_gaps":["No specific Item(s) of Form 8-K are identified in the provided text (material_items is empty).","No disclosed event details are present beyond generic forward-looking statements and references to other sections.","The \u201cChanges\u201d section content is not included in the provided excerpt, so what changed vs prior known state cannot be determined from this text alone.","No financial guidance, earnings figures, or quantitative implications are disclosed in the provided excerpt."],"key_facts":["The document is a SEC Form \u201cCurrent Report\u201d on Form 8-K.","The filing date shown in the source summary is 20260417 (SEC filing date provided as 2026-04-18T03:05:05.644967+00:00 in structured context).","The provided article text includes standard forward-looking statements language and references sections such as \u201cDescription of Business,\u201d \u201cRisk Factors,\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Plan of Operations.\u201d","The provided text includes a \u201cChanges\u201d heading, but no specific change details are included in the supplied excerpt."],"numeric_claims":[],"primary_claim":"Webstar Technology Group Inc. filed a Form 8-K (current report) with the SEC, with filing date shown as 20260417.","relevance_score":0.35,"sentiment":"neutral","source_quality":"high","summary":"Webstar Technology Group Inc. filed a Form 8-K on 2026-04-17 (reported as filed 20260417). The provided text contains only the standard 8-K cover/forward-looking statements language and does not include any specific \u201cChanges\u201d content or material item disclosures.","topics":["SEC filing","Form 8-K","forward-looking statements","risk factors (referenced)"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 8-K \u00b7 Webstar Technology Group Inc. \u00b7 Filed 20260417","ticker":"WBSR","tickers":["WBSR"],"title":"WBSR filed 8-K","url":"https://www.sec.gov/Archives/edgar/data/1645155/0001493152-26-017774.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_6f7c060ec {"_evidence_event_ids":["evt_6f7c060ec47f"]}...
|
signal_enriched:discovery_sec_filing_delta:db20470 signal_enriched:discovery_sec_filing_delta:db204704fc82db2a...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_59ddd43e31ed
|
evt_327d4704e419
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1437107/0001437107-26-000039.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1437107/0001437107-26-000039.txt","company":"Warner Bros. Discovery, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1437107/0001437107-26-000039.txt","article_chars":1597,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_f6cbce7e5eff21c0","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1437107/0001437107-26-000039.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:15:48.223435+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1437107/0001437107-26-000039.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1437107/0001437107-26-000039.txt","source_event_id":"evt_f4e0e9adcbfa","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"a8168bf541a62165","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.62,"dates_mentioned":["2026-04-15","2026-04-17","2026-04-18"],"entities":[{"asset_class":"equity","name":"Warner Bros. Discovery, Inc.","relevance":"high","symbol":"WBD","type":"issuer"},{"asset_class":"person","name":"Amy Girdwood","relevance":"high","symbol":"","type":"reporting-owner"},{"asset_class":"equity","name":"Series A Common Stock","relevance":"high","symbol":"","type":"security"}],"event_type":"other","information_gaps":["The provided text does not clearly state whether the Form 4 transaction was a purchase, sale, or other type (e.g., grant/option exercise).","The direction of the transaction (increase/decrease in holdings) is not explicitly stated in the provided excerpt.","The units and whether 225624 is shares, options, or another measure are not explicitly stated.","No prior known state is included in the prompt, so the 'what changed vs prior' delta cannot be determined from the provided text alone.","Currency for the 27.20 price is not explicitly stated in the excerpt."],"key_facts":["SEC accession number: 0001437107-26-000039.","Conformed submission type: Form 4.","Conformed period of report (transaction date): 2026-04-15.","Filed as of date: 2026-04-17.","Reporting owner: Amy Girdwood; role shown as Chief People & Culture Officer.","Issuer: Warner Bros. Discovery, Inc. (WBD).","Security listed: Series A Common Stock.","Price shown: 27.20 (currency not explicitly stated in provided text).","A quantity value appears as 225624 (units not explicitly stated in provided text)."],"numeric_claims":[{"label":"transaction_date","value":"2026-04-15"},{"label":"filed_as_of_date","value":"2026-04-17"},{"label":"price","value":"27.20"},{"label":"quantity_value_shown","value":"225624"}],"primary_claim":"On 2026-04-17, Warner Bros. Discovery, Inc. filed Form 4 for reporting-owner Amy Girdwood, covering a transaction in Series A Common Stock dated 2026-04-15 at a price of 27.20.","relevance_score":0.45,"sentiment":"neutral","source_quality":"medium","summary":"Warner Bros. Discovery, Inc. filed a Form 4 on 2026-04-17 covering reporting-owner Amy Girdwood (Chief People & Culture Officer). The filing includes a transaction involving Series A Common Stock dated 2026-04-15, with a reported price of 27.20.","topics":["SEC filing","Form 4","insider transaction","Warner Bros. Discovery","Series A Common Stock"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 Warner Bros. Discovery, Inc. \u00b7 Filed 20260417","ticker":"WBD","tickers":["WBD"],"title":"WBD filed 4","url":"https://www.sec.gov/Archives/edgar/data/1437107/0001437107-26-000039.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_f4e0e9adc {"_evidence_event_ids":["evt_f4e0e9adcbfa"]}...
|
signal_enriched:discovery_sec_filing_delta:9d3a1db signal_enriched:discovery_sec_filing_delta:9d3a1dba1918b89a...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_caf7461b9230
|
evt_08cbee94bc90
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/929008/0001193125-26-159688.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/929008/0001193125-26-159688.txt","company":"WESCO INTERNATIONAL INC","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/929008/0001193125-26-159688.txt","article_chars":4177,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_0034b7a1c1eff105","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/929008/0001193125-26-159688.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:16:28.213768+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"DEF 14A","final_url":"https://www.sec.gov/Archives/edgar/data/929008/0001193125-26-159688.txt","html_truncated":true,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/929008/0001193125-26-159688.txt","source_event_id":"evt_89f1694068ce","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"DEF 14A","fp":"577070edc85797dc","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-17","2026-04-18","May 27, 2026","December 31, 2026"],"entities":[{"asset_class":"equity","name":"WESCO INTERNATIONAL INC","relevance":"high","symbol":"","type":"issuer"},{"asset_class":"other","name":"Computershare","relevance":"medium","symbol":"","type":"transfer_agent"},{"asset_class":"other","name":"Broadridge Financial Solutions, Inc. (Broadridge)","relevance":"medium","symbol":"","type":"proxy_tabulator"},{"asset_class":"other","name":"Innisfree","relevance":"medium","symbol":"","type":"proxy_solicitor"},{"asset_class":"other","name":"PricewaterhouseCoopers LLP","relevance":"medium","symbol":"","type":"auditor"}],"event_type":"listing","information_gaps":["The excerpt does not specify the Annual Meeting date/time, record date, or the full list of matters/proposals included in the DEF 14A beyond the auditor ratification routine matter.","The provided text does not describe what changed versus a prior known state (no prior filing/version content was included in the signal).","No financial guidance or earnings/financial implications are disclosed in the provided excerpt."],"key_facts":["Shareholders may revoke/change a proxy by notifying the Corporate Secretary in writing received before 11:59 PM EDT on May 27, 2026; by sending another validly executed proxy dated later than the prior proxy received before 11:59 PM EDT on May 27, 2026; or by attending the virtual Annual Meeting and voting online during the open poll section.","Registered stockholders hold shares directly in their name with the transfer agent (Computershare); beneficial holders hold shares through an intermediary (e.g., bank/broker/nominee) in \u201cstreet name.\u201d","If a registered stockholder returns a signed proxy card without marking voting choices, shares will be voted as recommended by the Board on each matter presented.","For beneficial holders, the broker/bank/nominee votes as directed by the beneficial owner; if no instructions are given, brokers may vote only on routine matters.","The only routine matter proposed for stockholder vote is ratification of the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the year ending December 31, 2026.","Votes are tabulated by representatives of Broadridge, and a duly appointed inspector of election certifies examination of the stockholder list, shares/outstanding as of the record date, and quorum.","A quorum is met if holders of a majority of outstanding shares entitled to vote are present in person or by proxy; abstentions, broker non-votes, and votes withheld from director nominees count as shares present for quorum purposes.","Wesco pays costs of preparing proxy materials and soliciting votes; it engaged Innisfree to assist with solicitation for an estimated fee of $20,000 plus expenses.","Wesco will reimburse brokerage firms and other persons representing beneficial owners for reasonable expenses incurred in forwarding proxy-soliciting materials.","Proxies may be solicited by directors, officers, employees, and agents without additional remuneration by telephone, electronic or facsimile transmission, or in person.","Stockholders can elect to receive future Wesco proxy statements and annual reports via paper copies in the mail."],"numeric_claims":[{"label":"Innisfree estimated fee","value":"$20,000 plus expenses"},{"label":"Proxy revocation deadline (EDT)","value":"11:59 PM EDT on May 27, 2026"},{"label":"Auditor year ending","value":"December 31, 2026"}],"primary_claim":"WESCO INTERNATIONAL INC filed Form DEF 14A (proxy statement) on 2026-04-17 (as indicated by the source summary).","relevance_score":0.55,"sentiment":"neutral","source_quality":"high","summary":"WESCO INTERNATIONAL INC filed a DEF 14A proxy statement. The excerpted filing text explains how shareholders can revoke/change votes, differences between registered and beneficial holders, quorum/vote-counting, and proxy solicitation costs/agents.","topics":["proxy statement","shareholder voting","proxy revocation","quorum","vote tabulation","proxy solicitation","independent auditor ratification"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form DEF 14A \u00b7 WESCO INTERNATIONAL INC \u00b7 Filed 20260417","ticker":"WCC","tickers":["WCC"],"title":"WCC filed DEF 14A","url":"https://www.sec.gov/Archives/edgar/data/929008/0001193125-26-159688.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_89f169406 {"_evidence_event_ids":["evt_89f1694068ce"]}...
|
signal_enriched:discovery_sec_filing_delta:082874e signal_enriched:discovery_sec_filing_delta:082874e18910feab...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_1e0e85104a1e
|
evt_939e1de14640
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1990354/0001990354-26-000013.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1990354/0001990354-26-000013.txt","company":"Waystar Holding Corp.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1990354/0001990354-26-000013.txt","article_chars":908,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_84710b56e40440f5","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1990354/0001990354-26-000013.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:16:32.362881+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"way-20260417","final_url":"https://www.sec.gov/Archives/edgar/data/1990354/0001990354-26-000013.txt","html_truncated":true,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1990354/0001990354-26-000013.txt","source_event_id":"evt_2ef5983db40b","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"DEF 14A","fp":"5da2bd58b916ccaf","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-17","2025-12-31","2026-04-18T03:05:05.644967+00:00"],"entities":[{"asset_class":"equity","name":"Waystar Holding Corp.","relevance":"high","symbol":"","type":"issuer"}],"event_type":"listing","information_gaps":["What specific matters/items are included in the DEF 14A (e.g., director elections, executive compensation, proposals) is not provided in the cleaned text.","What changed versus the prior known state is not described; no prior filing comparison content is included.","No financial guidance or financial implications are disclosed in the provided text excerpt."],"key_facts":["SEC accession number: 0001990354-26-000013","Conformed submission type: DEF 14A","Public document count: 95","Conformed period of report: 2025-12-31","Filed as of date: 2026-04-17","Filer: company (Waystar Holding Corp.)","SEC file number: 001-42125","Business address: 1550 Digital Drive, #300, Lehi, UT 84043","Fiscal year end: 1231 (i.e., 2025-12-31)"],"numeric_claims":[{"label":"Public document count","value":"95"},{"label":"Conformed period of report","value":"2025-12-31"},{"label":"Filed as of date","value":"2026-04-17"},{"label":"SEC file number","value":"001-42125"}],"primary_claim":"Waystar Holding Corp. submitted Form DEF 14A (proxy statement) on 2026-04-17 (accession 0001990354-26-000013).","relevance_score":0.45,"sentiment":"neutral","source_quality":"medium","summary":"Waystar Holding Corp. filed a DEF 14A proxy statement with the SEC on 2026-04-17 for the fiscal period ending 2025-12-31.","topics":["SEC filing","DEF 14A","proxy statement","corporate governance"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form DEF 14A \u00b7 Waystar Holding Corp. \u00b7 Filed 20260417","ticker":"WAY","tickers":["WAY"],"title":"WAY filed DEF 14A","url":"https://www.sec.gov/Archives/edgar/data/1990354/0001990354-26-000013.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_2ef5983db {"_evidence_event_ids":["evt_2ef5983db40b"]}...
|
signal_enriched:discovery_sec_filing_delta:1e487f0 signal_enriched:discovery_sec_filing_delta:1e487f0d2913db7f...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_0b7643848394
|
evt_0a4a5cb15b05
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1990354/0001990354-26-000014.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1990354/0001990354-26-000014.txt","company":"Waystar Holding Corp.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1990354/0001990354-26-000014.txt","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_8d96ec82f8906c46","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1990354/0001990354-26-000014.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:16:36.739356+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"Document","final_url":"https://www.sec.gov/Archives/edgar/data/1990354/0001990354-26-000014.txt","html_truncated":true,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1990354/0001990354-26-000014.txt","source_event_id":"evt_c2b9454d133e","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"DEFA14A","fp":"252e2f5baed9ec17","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.9,"dates_mentioned":["2026-04-17"],"entities":[{"asset_class":"equity","name":"Waystar Holding Corp.","relevance":"high","symbol":"","type":"issuer"}],"event_type":"listing","information_gaps":["No disclosed purpose, amendments, or changes vs prior known state are included in the provided cleaned text.","The text does not include the contents of the DEFA14A (e.g., proxy materials, voting matters, or any financial/transaction implications).","No prior filing state is provided, so the specific delta/change cannot be determined from this signal alone."],"key_facts":["SEC accession number: 0001990354-26-000014.","Conformed submission type: DEFA14A.","Filed as of date: 2026-04-17.","Public document count: 5.","Filer: company (Waystar Holding Corp.).","SEC file number: 001-42125.","Business address: 1550 Digital Drive, #300, Lehi, UT 84043.","Fiscal year end: 1231."],"numeric_claims":[{"label":"public_document_count","value":"5"},{"label":"sec_file_number","value":"001-42125"}],"primary_claim":"Waystar Holding Corp. filed Form DEFA14A with the SEC on 2026-04-17 (accession number 0001990354-26-000014).","relevance_score":0.55,"sentiment":"neutral","source_quality":"high","summary":"Waystar Holding Corp. filed a DEFA14A proxy-related filing with the SEC on 2026-04-17 (accession 0001990354-26-000014). The provided text contains filing metadata but no substantive disclosure details.","topics":["SEC filing","DEFA14A","proxy-related filing","Waystar Holding Corp."]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form DEFA14A \u00b7 Waystar Holding Corp. \u00b7 Filed 20260417","ticker":"WAY","tickers":["WAY"],"title":"WAY filed DEFA14A","url":"https://www.sec.gov/Archives/edgar/data/1990354/0001990354-26-000014.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_c2b9454d1 {"_evidence_event_ids":["evt_c2b9454d133e"]}...
|
signal_enriched:discovery_sec_filing_delta:492c25e signal_enriched:discovery_sec_filing_delta:492c25e089355472...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_093d0025ba56
|
evt_f23a9de47578
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1212545/0001628280-26-025843.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1212545/0001628280-26-025843.txt","company":"WESTERN ALLIANCE BANCORPORATION","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1212545/0001628280-26-025843.txt","article_chars":2570,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_380400b4f6d252f2","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1212545/0001628280-26-025843.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:16:42.608175+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1212545/0001628280-26-025843.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1212545/0001628280-26-025843.txt","source_event_id":"evt_90df1f0036f6","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"c27ba6c62a4a8b08","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-15","2026-04-17","2026-04-16","March 2024","February 2027","March 2025","February 2028","March 2026","February 2029"],"entities":[{"asset_class":"equity","name":"Western Alliance Bancorporation","relevance":"high","symbol":"WAL","type":"issuer"},{"asset_class":"person","name":"Jessica H. Jarvi","relevance":"high","symbol":"","type":"reporting_owner"}],"event_type":"listing","information_gaps":["The provided text does not include the prior known state, so the specific \u201cdelta\u201d versus earlier filings cannot be determined from the supplied content.","The cleaned text shows repeated \u201cCommon Stock\u201d and \u201cCash Settled Restricted Stock Units\u201d lines, but the exact number of units/shares per tranche is not clearly extractable from the provided snippet (some numeric fields appear but are not unambiguously labeled).","No explicit transaction type (e.g., grant vs. acquisition vs. disposition) is stated in the provided excerpt beyond the RSU vesting/payment terms."],"key_facts":["SEC filing: Form 4 (CONFORMED SUBMISSION TYPE: 4).","Issuer: WESTERN ALLIANCE BANCORPORATION (CIK: 0001212545).","Reporting owner: Jarvi Jessica H (CIK: 0001981756).","Period of report: 20260415; filed as of date: 20260417; accession number: 0001628280-26-025843.","The filing includes multiple entries for \u201cCash Settled Restricted Stock Units\u201d tied to \u201cCommon Stock.\u201d","The filing states: \u201cThese units vest and are payable solely in cash as follows: 1/36th on the 15th day of each month during the 36-month period beginning March 2024 and ending February 2027.\u201d","The filing states a second vesting schedule: \u201c1/36th on the 15th day of each month during the 36-month period beginning March 2025 and ending February 2028.\u201d","The filing states a third vesting schedule: \u201c1/36th on the 15th day of each month during the 36-month period beginning March 2026 and ending February 2029.\u201d","The text includes: \u201cReflects shares held in the 401K Plan to include employer match as of 4/16/2026.\u201d"],"numeric_claims":[{"label":"Period of report","value":"2026-04-15"},{"label":"Filed as of date","value":"2026-04-17"},{"label":"Vesting cadence","value":"1/36th monthly on the 15th"},{"label":"Vesting window 1","value":"Mar 2024\u2013Feb 2027"},{"label":"Vesting window 2","value":"Mar 2025\u2013Feb 2028"},{"label":"Vesting window 3","value":"Mar 2026\u2013Feb 2029"}],"primary_claim":"A Form 4 for Western Alliance Bancorporation was filed on 2026-04-17 (period of report 2026-04-15) by reporting owner Jessica H. Jarvi, disclosing cash-settled RSUs tied to WAL common stock with specified monthly vesting and cash payment terms.","relevance_score":0.55,"sentiment":"neutral","source_quality":"high","summary":"Western Alliance Bancorporation (WAL) filed a Form 4 on 2026-04-17 covering transactions by reporting owner Jessica H. Jarvi. The filing discloses cash-settled restricted stock units (RSUs) in the issuer\u2019s common stock with monthly vesting schedules over multi-year periods.","topics":["SEC Form 4","insider transactions","restricted stock units","vesting schedule","cash-settled RSUs","401(k) plan"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 WESTERN ALLIANCE BANCORPORATION \u00b7 Filed 20260417","ticker":"WAL","tickers":["WAL"],"title":"WAL filed 4","url":"https://www.sec.gov/Archives/edgar/data/1212545/0001628280-26-025843.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_90df1f003 {"_evidence_event_ids":["evt_90df1f0036f6"]}...
|
signal_enriched:discovery_sec_filing_delta:3954d11 signal_enriched:discovery_sec_filing_delta:3954d1172a5894cf...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_bf2d78b9f7ad
|
evt_e38090114a4e
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1212545/0001628280-26-025845.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1212545/0001628280-26-025845.txt","company":"WESTERN ALLIANCE BANCORPORATION","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1212545/0001628280-26-025845.txt","article_chars":2605,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_eb7fa99a7b8c29c8","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1212545/0001628280-26-025845.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:16:48.160426+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1212545/0001628280-26-025845.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1212545/0001628280-26-025845.txt","source_event_id":"evt_0f46882c89b9","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"0cd18ece1dd08aba","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-17","2026-04-15","2024-03","2027-02","2025-03","2028-02","2026-03","2029-02"],"entities":[{"asset_class":"equity","name":"Western Alliance Bancorporation","relevance":"high","symbol":"WAL","type":"issuer"},{"asset_class":"person","name":"Kennedy Barbara","relevance":"high","symbol":"","type":"reporting_owner"},{"asset_class":"other","name":"Kennedy Family Trust","relevance":"medium","symbol":"","type":"trust"}],"event_type":"other","information_gaps":["The cleaned text does not clearly enumerate the transaction type (e.g., grant vs. acquisition vs. disposition) beyond describing cash-settled RSUs and vesting terms.","The cleaned text includes multiple RSU quantities/rows (e.g., 101, 74, 82) but does not provide a clearly labeled mapping of each quantity to a specific vesting tranche in a structured way.","No explicit prior-known state is provided in the prompt, so the 'what changed vs prior known state' cannot be determined from the supplied text alone."],"key_facts":["SEC accession number: 0001628280-26-025845.","Form type: 4.","Issuer: WESTERN ALLIANCE BANCORPORATION (WAL).","Filed as of date: 2026-04-17; conform ed period of report: 2026-04-15.","Reporting owner: Kennedy Barbara (Chief Human Resources Officer listed in filing values).","The filing includes cash settled restricted stock units (RSUs) tied to Western Alliance Bancorporation common stock.","The filing states each unit is the economic equivalent of one share of Western Alliance Bancorporation common stock.","Vesting/settlement terms described: units vest and are payable solely in cash via 1/36th on the 15th day of each month during a 36-month period beginning March 2024 and ending February 2027.","Additional vesting/settlement terms described: 1/36th on the 15th day of each month during a 36-month period beginning March 2025 and ending February 2028.","Additional vesting/settlement terms described: 1/36th on the 15th day of each month during a 36-month period beginning March 2026 and ending February 2029."],"numeric_claims":[{"label":"RSUs vesting fraction","value":"1/36th"},{"label":"Vesting period length (months)","value":"36"},{"label":"Common stock economic equivalence","value":"1 unit = 1 share economic equivalent"},{"label":"Filed as of date","value":"2026-04-17"},{"label":"Period of report","value":"2026-04-15"}],"primary_claim":"Form 4 for Western Alliance Bancorporation was filed on 2026-04-17 (period of report 2026-04-15) by reporting owner Kennedy Barbara, disclosing cash-settled restricted stock units with monthly vesting schedules and cash-only settlement.","relevance_score":0.55,"sentiment":"neutral","source_quality":"high","summary":"Western Alliance Bancorporation (WAL) filed a Form 4 on 2026-04-17 covering transactions reported for the period ending 2026-04-15 by reporting owner Kennedy Barbara. The filing discloses cash-settled restricted stock units (RSUs) that vest monthly over multi-year periods and are payable solely in cash.","topics":["SEC Form 4","insider transactions","restricted stock units (RSUs)","cash-settled equity awards","vesting schedule"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 WESTERN ALLIANCE BANCORPORATION \u00b7 Filed 20260417","ticker":"WAL","tickers":["WAL"],"title":"WAL filed 4","url":"https://www.sec.gov/Archives/edgar/data/1212545/0001628280-26-025845.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_0f46882c8 {"_evidence_event_ids":["evt_0f46882c89b9"]}...
|
signal_enriched:discovery_sec_filing_delta:dcfc135 signal_enriched:discovery_sec_filing_delta:dcfc13546bf5e168...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_70dd9d812f05
|
evt_86c4177607e0
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/19617/0000950103-26-005891.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/19617/0000950103-26-005891.txt","company":"JPMORGAN CHASE & CO","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/19617/0000950103-26-005891.txt","article_chars":1973,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_3e6d63ffff9ac0e2","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/19617/0000950103-26-005891.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:17:02.746482+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/19617/0000950103-26-005891.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/19617/0000950103-26-005891.txt","source_event_id":"evt_738b74903a6a","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"424B3","fp":"608d7493d4685b87","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.72,"dates_mentioned":["2026-04-17","2026-04-18"],"entities":[{"asset_class":"equity","name":"JPMorgan Chase & Co.","relevance":"high","symbol":"","type":"issuer"},{"asset_class":"other","name":"JPMorgan Chase Financial Company LLC","relevance":"high","symbol":"","type":"issuer_subsidiary"},{"asset_class":"other","name":"Securities and Exchange Commission","relevance":"medium","symbol":"","type":"regulator"}],"event_type":"listing","information_gaps":["The signal headline mentions \u201cVYLD,\u201d but the provided cleaned text does not identify VYLD or any specific security/notes by that name.","No pricing supplement, reopening supplement, product supplement, or underlying supplement details (terms, amounts, maturities, yields, or pricing) are included in the provided text.","The specific changes vs a prior known state are not described beyond the statement that the new prospectus/prospectus supplement supersede prior ones; prior content differences are not provided.","The exact Form 424B3 filing timestamp is not explicitly stated in the article text; only the SEC filing date is provided in the deterministic context."],"key_facts":["JPMorgan Chase & Co. and JPMorgan Chase Financial Company LLC filed with the SEC a prospectus dated April 17, 2026 and a prospectus supplement dated April 17, 2026.","The prospectus and prospectus supplement \u201csupersede each prospectus supplement and prospectus previously filed\u201d under specified registration statement file numbers.","The filing references use of the prospectus addendum and the Prospectus/Prospectus Supplement for reopening notes or market-making transactions of notes originally issued under prospectuses/supplements dated on or prior to April 17, 2026 (\u201cRelevant Supplement\u201d).","The SEC and state securities commissions have not approved or disapproved the notes or passed upon the accuracy or adequacy of the prospectus addendum, Prospectus Supplement, or Prospectus.","The filing states that any contrary representation is a criminal offense.","The notes are stated to be not bank deposits, not insured by the FDIC or any other governmental agency, and not obligations of or guaranteed by a bank.","The document date shown is April 17, 2026."],"numeric_claims":[],"primary_claim":"The Form 424B3 filing includes a prospectus and prospectus supplement dated April 17, 2026 that supersede previously filed prospectus supplements/prospectuses for multiple specified SEC registration statement file numbers.","relevance_score":0.45,"sentiment":"neutral","source_quality":"medium","summary":"JPMorgan Chase & Co. and JPMorgan Chase Financial Company LLC filed a Form 424B3 prospectus dated April 17, 2026 and a related prospectus supplement dated April 17, 2026. The filing states these documents supersede prior prospectus supplements/prospectuses for specified SEC registration statement file numbers and can be used for reopening notes/market-making transactions.","topics":["SEC filing","prospectus","prospectus supplement","supersedes prior filings","reopening notes","market-making transactions","FDIC insurance disclaimer","not bank deposits"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 424B3 \u00b7 JPMORGAN CHASE & CO \u00b7 Filed 20260417","ticker":"VYLD","tickers":["VYLD"],"title":"VYLD filed 424B3","url":"https://www.sec.gov/Archives/edgar/data/19617/0000950103-26-005891.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_738b74903 {"_evidence_event_ids":["evt_738b74903a6a"]}...
|
signal_enriched:discovery_sec_filing_delta:3a85be9 signal_enriched:discovery_sec_filing_delta:3a85be99d91baa70...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_f347ace85603
|
evt_2ef890a01be3
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/19617/0000950103-26-005893.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/19617/0000950103-26-005893.txt","company":"JPMORGAN CHASE & CO","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/19617/0000950103-26-005893.txt","article_chars":2609,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_4e790cc2f98cae94","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/19617/0000950103-26-005893.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:17:08.694491+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/19617/0000950103-26-005893.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/19617/0000950103-26-005893.txt","source_event_id":"evt_4fca6cf22795","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"424B3","fp":"6382977b065089db","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-17","2026-04-18"],"entities":[{"asset_class":"equity","name":"JPMorgan Chase & Co.","relevance":"primary","symbol":"","type":"issuer"},{"asset_class":"other","name":"JPMorgan Chase Financial Company LLC","relevance":"primary","symbol":"","type":"issuer"}],"event_type":"listing","information_gaps":["The signal indicates \u201cVYLD filed 424B3,\u201d but the provided text does not mention VYLD or any specific ticker/security name.","The text does not specify the offering size, terms, interest rate, maturity, or other financial details of the notes.","The table referenced in the text (for replacement/original supplements) is not included, so the specific replacement supplements are not enumerated.","No explicit description of what changed versus a prior known state is provided beyond the general replacement/supersession language."],"key_facts":["Form 424B3 was filed for JPMorgan Chase & Co. and JPMorgan Chase Financial Company LLC.","The prospectus is dated April 17, 2026, and the prospectus supplement is also dated April 17, 2026.","For preliminary pricing supplements with pricing dates after the prospectus addendum date, the filing includes product supplements labeled as \u201cReplacement Product Supplement.\u201d","For those preliminary pricing supplements, references to \u201cOriginal Product Supplement\u201d are deemed to refer instead to the corresponding \u201cReplacement Product Supplement.\u201d","The filing also includes \u201cReplacement Underlying Supplement\u201d documents, and references to \u201cOriginal Underlying Supplement\u201d are deemed to refer instead to the corresponding replacement underlying supplements.","The SEC and any state securities commission have not approved or disapproved the notes or passed upon the accuracy or adequacy of the prospectus addendum or related supplements.","The notes are not bank deposits, are not FDIC-insured, and are not obligations of or guaranteed by a bank.","The document date shown is April 17, 2026."],"numeric_claims":[],"primary_claim":"JPMorgan Chase & Co. and JPMorgan Chase Financial Company LLC filed a prospectus addendum (Form 424B3) dated April 17, 2026, including replacement product and underlying supplements that supersede original supplements for preliminary pricing supplements with pricing dates after the addendum date.","relevance_score":0.55,"sentiment":"neutral","source_quality":"high","summary":"JPMorgan Chase & Co. and JPMorgan Chase Financial Company LLC filed a Form 424B3 prospectus addendum dated April 17, 2026, along with related prospectus supplement and replacement supplement documents for certain offerings. The filing states that SEC/state approvals are not involved and that the notes are not bank deposits and are not FDIC-insured.","topics":["SEC filing","prospectus addendum","prospectus supplement","replacement product supplement","replacement underlying supplement","notes not bank deposits","no SEC/state approval"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 424B3 \u00b7 JPMORGAN CHASE & CO \u00b7 Filed 20260417","ticker":"VYLD","tickers":["VYLD"],"title":"VYLD filed 424B3","url":"https://www.sec.gov/Archives/edgar/data/19617/0000950103-26-005893.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_4fca6cf22 {"_evidence_event_ids":["evt_4fca6cf22795"]}...
|
signal_enriched:discovery_sec_filing_delta:f841f03 signal_enriched:discovery_sec_filing_delta:f841f03e23d62d53...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_7ec0f9cc0b57
|
evt_c0fcda762455
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/740260/0001203367-26-000012.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/740260/0001203367-26-000012.txt","company":"Ventas, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/740260/0001203367-26-000012.txt","article_chars":2532,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_93218b88fd74ab83","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/740260/0001203367-26-000012.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:18:14.695446+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/740260/0001203367-26-000012.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/740260/0001203367-26-000012.txt","source_event_id":"evt_df8138972597","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"e9bc49fe440221f6","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-17","2026-04-16","2026-04-17T03:05:05.644967+00:00","1998-05-07"],"entities":[{"asset_class":"equity","name":"Ventas, Inc.","relevance":"high","symbol":"VTR","type":"issuer"},{"asset_class":"person","name":"Matthew J. Lustig","relevance":"high","symbol":"","type":"reporting_owner"},{"asset_class":"other","name":"Lazard Freres & Co LLC","relevance":"low","symbol":"","type":"mail_address_company"}],"event_type":"listing","information_gaps":["What changed vs prior known state is not provided in the signal; only the current Form 4 content is shown.","The cleaned text does not explicitly label whether the transaction is an acquisition/disposition; it only describes dividend-equivalent credited units under deferral arrangements.","The table fields are partially shown without column headers, so the exact meaning of each numeric value (beyond being present in the filing table) cannot be fully confirmed from the provided text alone."],"key_facts":["SEC filing is Form 4 (CONFORMED SUBMISSION TYPE: 4) filed as of 2026-04-17 (FILED AS OF DATE: 20260417).","Issuer is Ventas, Inc. (ISSUER: COMPANY CONFORMED NAME: Ventas, Inc.; symbol shown as VTR).","Reporting owner is Matthew J. Lustig (REPORTING-OWNER: OWNER DATA: LUSTIG MATTHEW J).","The filing indicates the dividend equivalents relate to a dividend on Issuer\u2019s common stock paid on April 16, 2026 (dividend on Issuer's common stock paid on April 16, 2026).","The filing states units are payable solely in common stock and are subject to the reporting person\u2019s deferral election and the applicable plan/program terms.","One description references the Ventas, Inc. Non-Employee Directors' Cash Compensation Deferral Plan (\"Plan\").","Another description references the Ventas, Inc. Non-Employee Directors' Equity Award Deferral Program (\"Program\") adopted pursuant to the Ventas, Inc. 2022 Incentive Plan.","The filing includes numeric fields for two common stock entries with values shown in the cleaned text: 229.231 and 66.742 (share/unit quantities shown as part of the table) and corresponding amounts 92891.97 and 92958.712 (as displayed).","The filing signature line shows: Matthew J. Lustig, By: /s/ Jessica Stricklin, Attorney-In-Fact (2026-04-17)."],"numeric_claims":[{"label":"Quantity (first common stock entry shown)","value":"229.231"},{"label":"Quantity (second common stock entry shown)","value":"66.742"},{"label":"Amount (first entry shown)","value":"92891.97"},{"label":"Amount (second entry shown)","value":"92958.712"}],"primary_claim":"On 2026-04-17, Ventas, Inc. filed Form 4 reporting that Matthew J. Lustig received common stock units under director deferral arrangements as a result of dividend equivalents credited for a dividend paid on April 16, 2026.","relevance_score":0.55,"sentiment":"neutral","source_quality":"high","summary":"Ventas, Inc. (VTR) reported a Form 4 filed on 2026-04-17 covering dividend-equivalent credited units payable in Ventas common stock, tied to a dividend paid on 2026-04-16.","topics":["SEC Form 4","director compensation deferral plan","dividend equivalents","common stock units","Ventas common stock"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 Ventas, Inc. \u00b7 Filed 20260417","ticker":"VTR","tickers":["VTR"],"title":"VTR filed 4","url":"https://www.sec.gov/Archives/edgar/data/740260/0001203367-26-000012.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_df8138972 {"_evidence_event_ids":["evt_df8138972597"]}...
|
signal_enriched:discovery_sec_filing_delta:ad3a773 signal_enriched:discovery_sec_filing_delta:ad3a773034bfd365...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_ad660e05c143
|
evt_082f2b44a97e
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/740260/0001209170-26-000004.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/740260/0001209170-26-000004.txt","company":"Ventas, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/740260/0001209170-26-000004.txt","article_chars":2067,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_4b0d003f6f244937","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/740260/0001209170-26-000004.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:18:20.421707+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/740260/0001209170-26-000004.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/740260/0001209170-26-000004.txt","source_event_id":"evt_d579871650ba","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"ca24235eddf1002e","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.72,"dates_mentioned":["2026-04-17","2026-04-16","2026-04-18","2026-04-17 (accession filed as of date)","1998-05-07 (former company name change date)","2026-04-16 (dividend payment date)"],"entities":[{"asset_class":"equity","name":"Ventas, Inc.","relevance":"high","symbol":"VTR","type":"issuer"},{"asset_class":"person","name":"Michael J. Embler","relevance":"high","symbol":"","type":"reporting_person"},{"asset_class":"plan","name":"Non-Employee Directors' Equity Award Deferral Program","relevance":"medium","symbol":"","type":"program"},{"asset_class":"plan","name":"Ventas, Inc. 2022 Incentive Plan","relevance":"medium","symbol":"","type":"plan"}],"event_type":"listing","information_gaps":["What changed vs prior known state is not provided in the signal; no prior filing/position is included to compare.","The cleaned text includes several numbers (e.g., 66.742, 4, 0) but the mapping to specific fields (shares vs price vs transaction code) is not explicitly labeled in the provided excerpt.","The filing\u2019s specific transaction code (e.g., grant vs acquisition) and whether there are multiple transactions are not fully detailed beyond the narrative description.","No explicit statement of total holdings before/after is included in the provided text excerpt."],"key_facts":["SEC filing: Form 4 (CONFORMED SUBMISSION TYPE: 4).","Issuer: Ventas, Inc. (CIK 0000740260), ticker shown as VTR in the cleaned text.","Reporting person: Michael J. Embler (CIK 0001209170).","Filing metadata: filed as of 2026-04-17; conform ed period of report 2026-04-16; accession number 0001209170-26-000004.","Transaction description: common stock in the form of units granted under Ventas, Inc. Non-Employee Directors' Equity Award Deferral Program.","Cause of grant: dividend equivalents credited with respect to the dividend on Issuer's common stock paid on April 16, 2026.","Settlement/payability: units payable solely in common stock and subject to reporting person\u2019s deferral election and the Program.","Pricing reference: text states it \u201cRepresents the closing price per share of Issuer's common stock as of the grant date.\u201d","Signature: Michael J. Embler, By: /s/ Jessica Stricklin, Attorney-In-Fact; dated 2026-04-17."],"numeric_claims":[{"label":"Grant date closing price per share (as stated)","value":"85.51"},{"label":"Number of units/shares (as stated)","value":"14654.958"},{"label":"Another numeric value shown (context unclear)","value":"66.742"},{"label":"Another numeric value shown (context unclear)","value":"0"},{"label":"Another numeric value shown (context unclear)","value":"4"}],"primary_claim":"Form 4 for Ventas, Inc. was filed on 2026-04-17 (covering period 2026-04-16) showing Michael J. Embler received common stock units under the directors\u2019 equity award deferral program due to dividend equivalents credited for the dividend paid April 16, 2026.","relevance_score":0.55,"sentiment":"neutral","source_quality":"medium","summary":"Ventas, Inc. (VTR) filed a Form 4 on 2026-04-17 reporting a grant of common stock units to Michael J. Embler under the Non-Employee Directors' Equity Award Deferral Program. The filing states the units resulted from dividend equivalents credited for the dividend paid on 2026-04-16.","topics":["SEC Form 4","insider/director equity","deferral program","dividend equivalents","common stock units"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 Ventas, Inc. \u00b7 Filed 20260417","ticker":"VTR","tickers":["VTR"],"title":"VTR filed 4","url":"https://www.sec.gov/Archives/edgar/data/740260/0001209170-26-000004.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_d57987165 {"_evidence_event_ids":["evt_d579871650ba"]}...
|
signal_enriched:discovery_sec_filing_delta:e630cde signal_enriched:discovery_sec_filing_delta:e630cde380f9794f...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_10a93f6220d9
|
evt_0219303f9b20
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1606242/0001213900-26-045191.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1606242/0001213900-26-045191.txt","company":"Virtuix Holdings Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1606242/0001213900-26-045191.txt","article_chars":1823,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_f2337990a993531d","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1606242/0001213900-26-045191.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:18:24.770761+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1606242/0001213900-26-045191.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1606242/0001213900-26-045191.txt","source_event_id":"evt_8fc0dd49e535","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"0762851c8dde74a4","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.72,"dates_mentioned":["2026-04-17","2026-04-15","2026-04-16","2026-04-18"],"entities":[{"asset_class":"equity","name":"Virtuix Holdings Inc.","relevance":"high","symbol":"VTIX","type":"issuer"},{"asset_class":"person","name":"Jan Roger Goetgeluk","relevance":"high","symbol":"","type":"reporting_person"},{"asset_class":"equity","name":"Class A common stock, par value $0.001 per share","relevance":"high","symbol":"","type":"security"}],"event_type":"listing","information_gaps":["What changed vs prior known state is not provided in the signal (no prior filing details included).","The filing text excerpt does not include total remaining holdings, whether there were purchases, or any post-transaction ownership figures.","The excerpt does not explicitly state the total dollar proceeds; only per-share prices and share counts are shown."],"key_facts":["SEC filing type: Form 4.","Issuer: Virtuix Holdings Inc. (VTIX).","Reporting person: Jan Roger Goetgeluk (Chief Executive Officer).","Conformed period of report: 2026-04-15; filed as of date: 2026-04-17.","The filing reports a sale of 8,185 shares of Class A common stock on 2026-04-15 at a price of 6.40 (as shown in the filing values).","The filing reports a sale of 9,323 shares of Class A common stock on 2026-04-16 at a price of 6.14 (as shown in the filing values).","Both reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person prior to the Company\u2019s direct listing."],"numeric_claims":[{"label":"shares_sold_1","value":"8,185"},{"label":"sale_price_1","value":"6.40"},{"label":"shares_sold_2","value":"9,323"},{"label":"sale_price_2","value":"6.14"}],"primary_claim":"The Form 4 reports that Jan Roger Goetgeluk sold 8,185 shares on 2026-04-15 and 9,323 shares on 2026-04-16 of Virtuix Holdings Inc. Class A common stock under a Rule 10b5-1 trading plan adopted prior to the direct listing.","relevance_score":0.55,"sentiment":"neutral","source_quality":"medium","summary":"Virtuix Holdings Inc. (VTIX) filed a Form 4 on 2026-04-17 covering transactions by reporting person Jan Roger Goetgeluk. The filing reports sales of Class A common stock on 2026-04-15 and 2026-04-16 under a Rule 10b5-1 trading plan adopted prior to the company\u2019s direct listing.","topics":["SEC Form 4","insider transaction","Rule 10b5-1 trading plan","direct listing","Class A common stock sales"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 Virtuix Holdings Inc. \u00b7 Filed 20260417","ticker":"VTIX","tickers":["VTIX"],"title":"VTIX filed 4","url":"https://www.sec.gov/Archives/edgar/data/1606242/0001213900-26-045191.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_8fc0dd49e {"_evidence_event_ids":["evt_8fc0dd49e535"]}...
|
signal_enriched:discovery_sec_filing_delta:d2a9dba signal_enriched:discovery_sec_filing_delta:d2a9dbabc2a49502...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_1e89e2ff35d4
|
evt_7043c6388b25
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1793663/0001193125-26-160835.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1793663/0001193125-26-160835.txt","company":"VTEX","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1793663/0001193125-26-160835.txt","article_chars":2001,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_93c8f680b2b7a0c4","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1793663/0001193125-26-160835.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:18:31.018867+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1793663/0001193125-26-160835.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1793663/0001193125-26-160835.txt","source_event_id":"evt_6f6e60b612bf","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"13aa5591523f30ab","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.62,"dates_mentioned":["2026-04-17","2026-04-16","2025-02-28"],"entities":[{"asset_class":"equity","name":"VTEX","relevance":"high","symbol":"VTEX","type":"issuer"},{"asset_class":"person","name":"Gomes Andre Spolidoro Ferreira","relevance":"high","symbol":"","type":"reporting_person"},{"asset_class":"company","name":"Botsmark LLC","relevance":"medium","symbol":"","type":"agent_or_trading_plan_rep"}],"event_type":"listing","information_gaps":["The cleaned text does not clearly specify whether each listed share/price line corresponds to a sale or another transaction type beyond the general statement that transactions were sales.","No explicit prior-known state is provided in the prompt, so the 'delta' versus prior state cannot be determined from the provided text alone.","The filing 'material_items' are not extracted because the cleaned text does not include structured item-level details beyond the general Rule 10b5-1 statement and some transaction lines."],"key_facts":["SEC accession number: 0001193125-26-160835.","Form type: 4.","Issuer: VTEX (Central Index Key 0001793663), listed as NYSE: VTEX.","Reporting person: Gomes Andre Spolidoro Ferreira (Central Index Key 0001968955).","Conformed period of report: 2026-04-16; filed as of date: 2026-04-17.","The filing states transactions were sales effected pursuant to a Rule 10b5-1 Trading Plan adopted on February 28, 2025.","The filing states that because the issuer is a foreign private issuer under Rule 3a12-3(b), the reporting person's transactions are exempt from Sections 16(b) and 16(c) of the Securities Exchange Act of 1934.","The filing includes transactions involving Class A common shares with dates 2026-04-16 and quantities/prices shown in the cleaned text (e.g., 1,500 shares at $4.12; 43,900 shares at $4.11), but the cleaned text does not explicitly label buy vs sell for each line beyond the general statement of sales."],"numeric_claims":[{"label":"Rule 10b5-1 plan adoption date","value":"2025-02-28"},{"label":"Conformed period of report (transaction date)","value":"2026-04-16"},{"label":"Filed as of date","value":"2026-04-17"},{"label":"Quantity (line shown)","value":"1500"},{"label":"Price (line shown)","value":"4.12"},{"label":"Quantity (line shown)","value":"43900"},{"label":"Price (line shown)","value":"4.11"}],"primary_claim":"VTEX (NYSE: VTEX) filed Form 4 on 2026-04-17 for reporting person Andre Spolidoro Gomes, with transactions in Class A common shares dated 2026-04-16 under a Rule 10b5-1 trading plan adopted 2025-02-28.","relevance_score":0.55,"sentiment":"neutral","source_quality":"medium","summary":"VTEX filed a Form 4 on 2026-04-17 covering transactions by reporting person Andre Spolidoro Gomes for Class A common shares. The filing indicates the sales were made under a Rule 10b5-1 trading plan adopted on 2025-02-28.","topics":["SEC Form 4","insider transaction","Rule 10b5-1 trading plan","Class A common shares","foreign private issuer exemption"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 VTEX \u00b7 Filed 20260417","ticker":"VTEX","tickers":["VTEX"],"title":"VTEX filed 4","url":"https://www.sec.gov/Archives/edgar/data/1793663/0001193125-26-160835.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_6f6e60b61 {"_evidence_event_ids":["evt_6f6e60b612bf"]}...
|
signal_enriched:discovery_sec_filing_delta:e1c81fd signal_enriched:discovery_sec_filing_delta:e1c81fd6abc1b9f4...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_c0c09fa1d1ec
|
evt_cff3867175c8
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/875320/0000875320-26-000159.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/875320/0000875320-26-000159.txt","company":"VERTEX PHARMACEUTICALS INC / MA","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/875320/0000875320-26-000159.txt","article_chars":1666,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_087d1fb22c03313e","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/875320/0000875320-26-000159.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:18:37.304350+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/875320/0000875320-26-000159.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/875320/0000875320-26-000159.txt","source_event_id":"evt_15b39a1e02d7","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"fca7c931e9bee665","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.62,"dates_mentioned":["2026-04-15","2026-04-17","2026-04-18T03:05:05.644967+00:00"],"entities":[{"asset_class":"equity","name":"VERTEX PHARMACEUTICALS INC / MA","relevance":"high","symbol":"VRTX","type":"issuer"},{"asset_class":"person","name":"Alan M. Garber","relevance":"high","symbol":"","type":"reporting_owner"},{"asset_class":"person","name":"Garber Alan M","relevance":"medium","symbol":"","type":"reporting_owner_name_variant"}],"event_type":"other","information_gaps":["The cleaned text does not explicitly state whether the deferred stock units were acquired, disposed, or otherwise changed versus a prior state; it only provides the Form 4 content shown.","The signal type is \u201cdiscovery_sec_filing_delta,\u201d but no prior known state or comparison data is included in the provided text, so \u201cwhat changed vs prior\u201d cannot be determined.","The meaning of the numeric fields \u201c33.898\u201d and \u201c442.50\u201d is not fully explained in the provided text (e.g., whether 33.898 is the number of units and 442.50 is a total value).","No transaction code (e.g., acquisition/disposition) or explicit \u201cchange\u201d amount is shown in the provided excerpt beyond the descriptive DSU settlement language."],"key_facts":["SEC accession number: 0000875320-26-000159.","Form type: 4 (Form 4).","Issuer: VERTEX PHARMACEUTICALS INC / MA (CIK shown as 0000875320).","Reporting owner: Garber Alan M (CIK shown as 0001312907).","Conformed period of report: 20260415; filed as of date: 20260417.","The filing includes an entry labeled \u201cDeferred Stock Units\u201d with date 2026-04-15.","The filing states: \u201cEach deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Garber's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Garber's disability or death.\u201d","The filing includes a common stock price/amount field shown as \u201c33.898\u201d and \u201c442.50\u201d (exact interpretation of these fields beyond the text is not provided)."],"numeric_claims":[{"label":"Deferred stock units date","value":"2026-04-15"},{"label":"Quantity shown (deferred stock units)","value":"33.898"},{"label":"Value shown","value":"442.50"},{"label":"Filing date (as of date)","value":"2026-04-17"},{"label":"Conformed period of report","value":"2026-04-15"}],"primary_claim":"On 2026-04-17, Vertex Pharmaceuticals filed Form 4 reporting deferred stock units held by Alan M. Garber, with each deferred stock unit representing one share of common stock and payable upon specified events.","relevance_score":0.45,"sentiment":"neutral","source_quality":"medium","summary":"Vertex Pharmaceuticals (VRTX) filed a Form 4 on 2026-04-17 for reporting period 2026-04-15 by reporting owner Alan M. Garber. The filing discloses deferred stock units that are settled in common stock upon specified triggering events.","topics":["SEC Form 4","insider transaction disclosure","deferred stock units","common stock settlement","board service termination","change of control","disability or death"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 VERTEX PHARMACEUTICALS INC / MA \u00b7 Filed 20260417","ticker":"VRTX","tickers":["VRTX"],"title":"VRTX filed 4","url":"https://www.sec.gov/Archives/edgar/data/875320/0000875320-26-000159.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_15b39a1e0 {"_evidence_event_ids":["evt_15b39a1e02d7"]}...
|
signal_enriched:discovery_sec_filing_delta:25c19a5 signal_enriched:discovery_sec_filing_delta:25c19a536ee051ce...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_f54f724798b7
|
evt_82a6a8058d63
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/875320/0000875320-26-000161.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/875320/0000875320-26-000161.txt","company":"VERTEX PHARMACEUTICALS INC / MA","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/875320/0000875320-26-000161.txt","article_chars":1701,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_434a224248b2266e","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/875320/0000875320-26-000161.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:19:23.716531+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/875320/0000875320-26-000161.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/875320/0000875320-26-000161.txt","source_event_id":"evt_a4af2c737339","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"378c3ada1a5baafe","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.62,"dates_mentioned":["2026-04-17","2026-04-15","2026-04-17T03:05:05.644967+00:00"],"entities":[{"asset_class":"equity","name":"VERTEX PHARMACEUTICALS INC / MA","relevance":"high","symbol":"VRTX","type":"issuer"},{"asset_class":"person","name":"SACHS BRUCE I","relevance":"high","symbol":"","type":"reporting_owner"},{"asset_class":"equity","name":"Common Stock","relevance":"high","symbol":"","type":"security"}],"event_type":"listing","information_gaps":["What specifically changed vs prior known state is not provided in the signal (no prior Form 4 state or comparison data included).","The provided text does not clearly label which numeric values (107.345, 442.50, 15671.866) correspond to which Form 4 fields (e.g., number of units, transaction price, total value).","No explicit transaction type (e.g., grant, vesting, acquisition) is stated beyond the presence of \u201cDeferred Stock Units.\u201d","No guidance or financial implications for the company are explicitly disclosed in the provided text."],"key_facts":["SEC accession number: 0000875320-26-000161.","Form type: 4 (Form 4).","Conformed period of report: 20260415; filed as of date: 20260417.","Reporting owner: Bruce I. Sachs (CENTRAL INDEX KEY: 0001197036).","The filing includes \u201cDeferred Stock Units\u201d with a date shown as 2026-04-15.","The filing states: \u201cEach deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death.\u201d","A price/amount line appears in the text: \u201c107.345\u201d and \u201c442.50\u201d and \u201c107.345 15671.866 D\u201d (exact mapping to fields is not explicitly labeled in the provided text)."],"numeric_claims":[{"label":"Price shown","value":"107.345"},{"label":"Amount shown","value":"442.50"},{"label":"Quantity shown","value":"15671.866"}],"primary_claim":"A Form 4 was filed by Vertex Pharmaceuticals (VRTX) on 2026-04-17 for reporting-owner Bruce I. Sachs, including deferred stock units tied to common stock.","relevance_score":0.45,"sentiment":"neutral","source_quality":"medium","summary":"Vertex Pharmaceuticals (VRTX) filed a Form 4 on 2026-04-17 covering a transaction related to deferred stock units held by Bruce I. Sachs. The filing states each deferred stock unit represents one share of common stock and is paid out in common stock upon specified triggering events.","topics":["SEC Form 4","insider/deferred stock units","common stock payout mechanics"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 VERTEX PHARMACEUTICALS INC / MA \u00b7 Filed 20260417","ticker":"VRTX","tickers":["VRTX"],"title":"VRTX filed 4","url":"https://www.sec.gov/Archives/edgar/data/875320/0000875320-26-000161.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_a4af2c737 {"_evidence_event_ids":["evt_a4af2c737339"]}...
|
signal_enriched:discovery_sec_filing_delta:b419ee9 signal_enriched:discovery_sec_filing_delta:b419ee9f889f4bdd...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_a772bbc172e4
|
evt_a1578ebafb10
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/883237/0000883237-26-000017.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/883237/0000883237-26-000017.txt","company":"VIRTUS INVESTMENT PARTNERS, INC.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/883237/0000883237-26-000017.txt","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_093a9c9d5376ca11","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/883237/0000883237-26-000017.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:19:29.537682+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"vrts-20260417","final_url":"https://www.sec.gov/Archives/edgar/data/883237/0000883237-26-000017.txt","html_truncated":true,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/883237/0000883237-26-000017.txt","source_event_id":"evt_3b778203143f","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"8-K","fp":"0c4237590814c5f6","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.86,"dates_mentioned":["2026-04-17","2026-04-18","first quarter 2026","first quarter 2024","fourth quarter 2025","fiscal 2024","fiscal 2025"],"entities":[{"asset_class":"equity","name":"VIRTUS INVESTMENT PARTNERS, INC.","relevance":"high","symbol":"VRTS","type":"issuer"}],"event_type":"regulation","information_gaps":["The specific prior non-GAAP definitions being revised are not reproduced in the provided text beyond stating that the tax benefits were previously excluded.","The actual numerical impact on the affected non-GAAP metrics (e.g., revised effective tax rate or EPS amounts) is not included in the provided excerpt; it is referenced as being in Exhibit 99.1.","The excerpt does not specify whether any other items besides the listed four non-GAAP measures are affected beyond the stated non-impact list."],"key_facts":["The filing is a Form 8-K (Current Report) dated April 17, 2026, filed in connection with Item 7.01 (Regulation FD Disclosure).","The Company will implement a revision to the definitions of certain non-GAAP financial measures to include tax benefits realized on amortization of goodwill and intangible assets commencing with the release of its first quarter 2026 results.","The tax benefit amounts had been previously excluded from these non-GAAP measures.","Including these tax benefits will impact the calculation of: (1) Non-GAAP effective tax rate, (2) Earnings per share\u2014diluted, as adjusted, (3) Tax expense, as adjusted, and (4) Net income attributable to common stockholders, as adjusted.","The revision will not impact other non-GAAP financial measures including revenues, as adjusted; operating expenses, as adjusted; operating income, as adjusted; and operating margin, as adjusted.","Management states the change better reflects underlying financial performance because acquisitions created an intangible tax asset generating meaningful tax benefits that have increased in size and economic impact.","The Company provides reconciliations of the most comparable U.S. GAAP measure to revised and historical non-GAAP measures for first quarter 2024 through fourth quarter 2025, and full year reconciliations for fiscal 2024 and 2025.","The supplemental information is attached as Exhibit 99.1 and is incorporated by reference.","The Company states the supplemental information does not restate or amend any financial results presented in periodic filings."],"numeric_claims":[],"primary_claim":"The Company will revise the definitions of certain non-GAAP financial measures to include tax benefits realized on amortization of goodwill and intangible assets beginning with the release of its first quarter 2026 results.","relevance_score":0.62,"sentiment":"neutral","source_quality":"high","summary":"Virtus Investment Partners, Inc. filed an 8-K to disclose a revision to its non-GAAP financial measure definitions starting with its first quarter 2026 results. The change adds tax benefits realized on amortization of goodwill and intangible assets to certain non-GAAP metrics, with reconciliations provided for prior periods.","topics":["8-K","Regulation FD disclosure","non-GAAP financial measures","goodwill and intangible assets amortization","tax benefits","earnings per share (diluted, as adjusted)","non-GAAP effective tax rate","reconciliations","Exhibit 99.1"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 8-K \u00b7 VIRTUS INVESTMENT PARTNERS, INC. \u00b7 Filed 20260417","ticker":"VRTS","tickers":["VRTS"],"title":"VRTS filed 8-K","url":"https://www.sec.gov/Archives/edgar/data/883237/0000883237-26-000017.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_3b7782031 {"_evidence_event_ids":["evt_3b778203143f"]}...
|
signal_enriched:discovery_sec_filing_delta:ad9ae9f signal_enriched:discovery_sec_filing_delta:ad9ae9f0db2406f6...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_e950b9a2cc6b
|
evt_29df9cf1e351
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1361113/0001140361-26-015263.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1361113/0001140361-26-015263.txt","company":"VARONIS SYSTEMS INC","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1361113/0001140361-26-015263.txt","article_chars":3760,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_43de4e63bf155a2f","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1361113/0001140361-26-015263.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:19:35.960235+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1361113/0001140361-26-015263.txt","html_truncated":true,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1361113/0001140361-26-015263.txt","source_event_id":"evt_6931d971f8b9","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"DEF 14A","fp":"a6f3373b51b1ae43","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2024 Annual Meeting of Shareholders"],"entities":[{"asset_class":"equity","name":"Varonis Systems Inc","relevance":"high","symbol":"","type":"issuer"},{"asset_class":"regulation","name":"SEC","relevance":"medium","symbol":"","type":"regulator"},{"asset_class":"governance","name":"Compensation Committee","relevance":"medium","symbol":"","type":"board_committee"},{"asset_class":"governance","name":"Board of Directors","relevance":"medium","symbol":"","type":"board"}],"event_type":"listing","information_gaps":["What changed vs prior known state is not provided in the signal; only that VRNS filed DEF 14A is indicated.","The filing date in the deterministic context (2026-04-18T03:05:05.644967+00:00) conflicts with the source summary text (Filed 20260417); the exact SEC filing timestamp is not fully reconciled from provided text.","No details are provided here about the specific named executive officers or the compensation amounts/metrics.","No other DEF 14A items (e.g., director elections, audit matters) are included in the provided excerpt."],"key_facts":["The company requests a non-binding shareholder vote to approve the compensation of its named executive officers.","The compensation to be approved is disclosed in the \u201cCompensation Discussion and Analysis\u201d section and the compensation tables and narrative discussion in the \u201cExecutive Compensation\u201d section.","The proposal is described as a \u201csay-on-pay\u201d proposal and is advisory (not binding) on the company, its Compensation Committee, or its Board of Directors.","The company states it presents a say-on-pay vote every year, referencing the results of a vote conducted at the 2024 Annual Meeting regarding say-on-pay frequency.","The proxy states the vote provides information about investor sentiment that the Compensation Committee can consider when determining executive compensation going forward.","The proxy states that if there is any significant vote against compensation, the company will endeavor to communicate with shareholders to understand concerns and evaluate whether actions are necessary.","The board recommends a vote for approval of the compensation of the company\u2019s named executive officers."],"numeric_claims":[],"primary_claim":"The proxy statement requests a non-binding shareholder vote to approve the compensation of the company\u2019s named executive officers as disclosed in the Compensation Discussion and Analysis and Executive Compensation sections.","relevance_score":0.45,"sentiment":"neutral","source_quality":"high","summary":"Varonis Systems Inc. filed a DEF 14A proxy statement that includes a non-binding \u201csay-on-pay\u201d proposal to approve the compensation of its named executive officers. The board recommends shareholders vote in favor.","topics":["DEF 14A proxy statement","say-on-pay","executive compensation","shareholder advisory vote","board recommendation"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form DEF 14A \u00b7 VARONIS SYSTEMS INC \u00b7 Filed 20260417","ticker":"VRNS","tickers":["VRNS"],"title":"VRNS filed DEF 14A","url":"https://www.sec.gov/Archives/edgar/data/1361113/0001140361-26-015263.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_6931d971f {"_evidence_event_ids":["evt_6931d971f8b9"]}...
|
signal_enriched:discovery_sec_filing_delta:b6054db signal_enriched:discovery_sec_filing_delta:b6054dbae379bc86...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_8d5de8a86e37
|
evt_4bea776c2391
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1361113/0001140361-26-015264.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1361113/0001140361-26-015264.txt","company":"VARONIS SYSTEMS INC","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1361113/0001140361-26-015264.txt","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_fa2870eeb78aea57","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1361113/0001140361-26-015264.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:19:42.725596+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1361113/0001140361-26-015264.txt","html_truncated":true,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1361113/0001140361-26-015264.txt","source_event_id":"evt_040873e25bab","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"DEFA14A","fp":"eb15d274973e9277","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.86,"dates_mentioned":["2026-04-17","2026-04-18T03:05:05.644967+00:00"],"entities":[{"asset_class":"equity","name":"Varonis Systems, Inc.","relevance":"primary","symbol":"","type":"issuer"},{"asset_class":"regulator","name":"U.S. Securities and Exchange Commission","relevance":"context","symbol":"","type":"regulator"}],"event_type":"listing","information_gaps":["No substantive content of the DEFA14A is included in the provided cleaned text beyond the filing header and the start of the document (the main proposal/additional materials details are not visible).","No explicit comparison to a prior known state is provided in the text (what changed vs prior filings is not stated).","The 'Amendment No.' field is shown as blank/unspecified in the provided excerpt."],"key_facts":["SEC filing type: DEFA14A (Definitive Additional Materials).","Filer/issuer: VARONIS SYSTEMS INC.","Filed as of date: 2026-04-17 (accession number: 0001140361-26-015264).","Document count reported: 3.","The filing is a Schedule 14A proxy statement pursuant to Section 14(a) of the Securities Exchange Act of 1934.","Payment of filing fee: No fee required (checked box).","Central Index Key (CIK): 0001361113.","Fiscal year end: 1231."],"numeric_claims":[{"label":"Document count","value":"3"},{"label":"SEC file number","value":"001-36324"},{"label":"CIK","value":"0001361113"},{"label":"Filed as of date","value":"2026-04-17"}],"primary_claim":"VARONIS SYSTEMS INC filed Form DEFA14A (definitive additional materials) on 2026-04-17 with the SEC.","relevance_score":0.55,"sentiment":"neutral","source_quality":"high","summary":"Varonis Systems, Inc. filed a definitive additional materials proxy statement on Form DEFA14A with the SEC on 2026-04-17. The provided text includes filing metadata and the beginning of the DEFA14A proxy statement, but does not show any substantive proposal details.","topics":["SEC filing","proxy statement","DEFA14A","Schedule 14A","corporate governance"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form DEFA14A \u00b7 VARONIS SYSTEMS INC \u00b7 Filed 20260417","ticker":"VRNS","tickers":["VRNS"],"title":"VRNS filed DEFA14A","url":"https://www.sec.gov/Archives/edgar/data/1361113/0001140361-26-015264.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_040873e25 {"_evidence_event_ids":["evt_040873e25bab"]}...
|
signal_enriched:discovery_sec_filing_delta:7eb1662 signal_enriched:discovery_sec_filing_delta:7eb1662fa4354cb3...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_a05dea48e99d
|
evt_ec225b8f034e
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1104038/0001214659-26-004807.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1104038/0001214659-26-004807.txt","company":"VerifyMe, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1104038/0001214659-26-004807.txt","article_chars":4518,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_63bae6bd7eeac4c7","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1104038/0001214659-26-004807.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:19:48.854334+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1104038/0001214659-26-004807.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1104038/0001214659-26-004807.txt","source_event_id":"evt_36cb23e0ce47","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"8-K","fp":"8e0a3182a5bf2bdc","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.86,"dates_mentioned":["2026-04-17","2026-10-14"],"entities":[{"asset_class":"equity","name":"VerifyMe, Inc.","relevance":"high","symbol":"VRME","type":"issuer"},{"asset_class":"other","name":"The Nasdaq Stock Market LLC","relevance":"high","symbol":"","type":"exchange"},{"asset_class":"other","name":"Nasdaq Listing Qualifications Staff","relevance":"high","symbol":"","type":"regulator_staff"}],"event_type":"listing","information_gaps":["The specific Nasdaq letter number/date and any additional details beyond the bid price noncompliance are not provided in the cleaned text.","The filing_date in the provided structured context (2026-04-18T03:05:05.644967+00:00) is not explicitly stated in the article text; only the letter date (April 17, 2026) is explicitly mentioned.","No prior known state is included in the prompt, so the exact delta versus previously known compliance status cannot be quantified beyond stating that this 8-K discloses the noncompliance and compliance timeline."],"key_facts":["VerifyMe, Inc. received a letter from Nasdaq on April 17, 2026.","Nasdaq indicated the company no longer meets Nasdaq Listing Rule 5550(a)(2).","Rule 5550(a)(2) requires a minimum bid price of at least $1 per share.","The noncompliance is based on the closing bid price for the last 30 consecutive business days.","Nasdaq Listing Rule 5810(c)(3)(A) provides a compliance period of 180 calendar days or until October 14, 2026 to regain compliance.","If the company evidences a closing bid price of at least $1 per share for at least 10 consecutive business days during the 180-day compliance period, it will automatically regain compliance.","If the company does not regain compliance by October 14, 2026, it may be eligible for a second 180-day compliance period if it meets continued listing requirements for market value of publicly held shares and all other initial listing standards for Nasdaq\u2019s Capital Market, other than the minimum bid price requirement.","For a second compliance period, the company would be required to notify Nasdaq of its intent to cure the minimum bid price deficiency.","If the company fails to regain compliance with continued listing standards, Nasdaq will provide notice that the company\u2019s common stock will be subject to delisting.","The company would be entitled to appeal that determination to a Nasdaq hearings panel.","The notification has no immediate effect on the listing of the company\u2019s common stock on Nasdaq.","The company intends to monitor the closing bid price and consider available options if the bid price remains below $1 per share."],"numeric_claims":[{"label":"Minimum bid price requirement (Nasdaq Rule 5550(a)(2))","value":"$1 per share"},{"label":"Lookback period for noncompliance","value":"30 consecutive business days"},{"label":"Primary compliance period","value":"180 calendar days (or until October 14, 2026)"},{"label":"Automatic cure condition","value":"$1 closing bid price for at least 10 consecutive business days during the 180-day period"},{"label":"Second compliance period (potential)","value":"second 180-day compliance period"}],"primary_claim":"On April 17, 2026, Nasdaq notified VerifyMe, Inc. that it no longer meets Nasdaq Listing Rule 5550(a)(2) due to the closing bid price being below $1 for the last 30 consecutive business days.","relevance_score":0.78,"sentiment":"negative","source_quality":"high","summary":"VerifyMe, Inc. filed a Form 8-K disclosing that Nasdaq notified the company it no longer meets the $1 minimum bid price requirement. The company has until October 14, 2026 to regain compliance, with potential eligibility for a second compliance period if other conditions are met.","topics":["Nasdaq minimum bid price noncompliance","Listing compliance period","Potential delisting and appeal process","Form 8-K disclosure"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 8-K \u00b7 VerifyMe, Inc. \u00b7 Filed 20260417","ticker":"VRME","tickers":["VRME"],"title":"VRME filed 8-K","url":"https://www.sec.gov/Archives/edgar/data/1104038/0001214659-26-004807.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_36cb23e0c {"_evidence_event_ids":["evt_36cb23e0ce47"]}...
|
signal_enriched:discovery_sec_filing_delta:389cc93 signal_enriched:discovery_sec_filing_delta:389cc9352bb41c77...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_c0421f3e6df2
|
evt_5555c3ef8c29
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1590750/0001193125-26-160344.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1590750/0001193125-26-160344.txt","company":"Viridian Therapeutics, Inc.\\DE","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1590750/0001193125-26-160344.txt","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_5849504e97dea372","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1590750/0001193125-26-160344.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:19:54.927634+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"DEF 14A","final_url":"https://www.sec.gov/Archives/edgar/data/1590750/0001193125-26-160344.txt","html_truncated":true,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1590750/0001193125-26-160344.txt","source_event_id":"evt_50ee6915ada1","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"DEF 14A","fp":"0cef2a1870985d58","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-06-02","2026-04-07","2026-04-17","2026-04-18"],"entities":[{"asset_class":"equity","name":"Viridian Therapeutics, Inc.","relevance":"high","symbol":"VRDN","type":"issuer"},{"asset_class":"other","name":"U.S. Securities and Exchange Commission (SEC)","relevance":"medium","symbol":"","type":"regulator"},{"asset_class":"other","name":"VirtualShareholderMeeting.com","relevance":"low","symbol":"","type":"meeting_platform"}],"event_type":"listing","information_gaps":["The specific proposals/items included in the proxy statement are not present in the provided text excerpt (e.g., director nominees, voting matters).","The excerpt does not describe any changes versus a prior known state beyond the fact that this DEF 14A was filed.","No details are provided about executive compensation or equity compensation utilization beyond general forward-looking statement language."],"key_facts":["Form DEF 14A is a proxy statement for Viridian Therapeutics, Inc. (the \u201cCompany\u201d).","The 2026 Annual Meeting of Stockholders will be held on Tuesday, June 2, 2026 at 2:00 p.m. Eastern Time.","The Annual Meeting will be a virtual meeting conducted exclusively online via live audio webcast at www.virtualshareholdermeeting.com/VRDN2026.","The Board fixed April 7, 2026 as the record date.","Only stockholders of record at the close of business on April 7, 2026 are entitled to notice of, and to vote at, the Annual Meeting (and any adjournment or postponement).","The proxy materials are first being made available to stockholders on or about April 17, 2026.","The proxy materials are furnished primarily via the internet pursuant to SEC rules (instead of mailing printed copies)."],"numeric_claims":[{"label":"Annual Meeting date","value":"2026-06-02"},{"label":"Annual Meeting time (ET)","value":"2:00 p.m."},{"label":"Record date","value":"2026-04-07"},{"label":"Proxy materials availability date (approx.)","value":"2026-04-17"}],"primary_claim":"Viridian Therapeutics, Inc. filed Form DEF 14A for its 2026 Annual Meeting of Stockholders, scheduled for June 2, 2026 (virtual) with a record date of April 7, 2026.","relevance_score":0.55,"sentiment":"neutral","source_quality":"high","summary":"Viridian Therapeutics, Inc. filed a DEF 14A proxy statement for its 2026 Annual Meeting of Stockholders. The filing states the meeting will be held virtually on June 2, 2026, with April 7, 2026 as the record date.","topics":["SEC filing","DEF 14A","proxy statement","annual meeting","virtual meeting","record date","stockholder voting"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form DEF 14A \u00b7 Viridian Therapeutics, Inc.\\DE \u00b7 Filed 20260417","ticker":"VRDN","tickers":["VRDN"],"title":"VRDN filed DEF 14A","url":"https://www.sec.gov/Archives/edgar/data/1590750/0001193125-26-160344.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_50ee6915a {"_evidence_event_ids":["evt_50ee6915ada1"]}...
|
signal_enriched:discovery_sec_filing_delta:b530190 signal_enriched:discovery_sec_filing_delta:b5301901908fefd8...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_97233d3cd8c9
|
evt_ec4bcdad32e5
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1590750/0001193125-26-160349.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1590750/0001193125-26-160349.txt","company":"Viridian Therapeutics, Inc.\\DE","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1590750/0001193125-26-160349.txt","article_chars":1964,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_c275815294afddef","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1590750/0001193125-26-160349.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:19:59.131994+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"DEFA14A","final_url":"https://www.sec.gov/Archives/edgar/data/1590750/0001193125-26-160349.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1590750/0001193125-26-160349.txt","source_event_id":"evt_87466dad76c5","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"DEFA14A","fp":"6814e3ce280c9a73","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.72,"dates_mentioned":["2026-04-17","June 2, 2026","May 19, 2026"],"entities":[{"asset_class":"equity","name":"Viridian Therapeutics, Inc.","relevance":"high","symbol":"","type":"issuer"}],"event_type":"listing","information_gaps":["No specific proxy proposals, resolutions, or voting items are included in the provided text (only an overview/availability notice).","The filing\u2019s \u201cAmendment No.\u201d value is blank in the provided text.","No prior known state is provided in the prompt, so the exact delta vs prior filings cannot be determined from the supplied content."],"key_facts":["The document is a Schedule 14A information statement (proxy statement) under Section 14(a) of the Securities Exchange Act of 1934.","The filing indicates it is filed by the registrant (\u2612 Filed by the Registrant).","The notice states the stockholder meeting will be held on June 2, 2026.","The notice states stockholders can view the proxy statement, notice, and annual report online or request free paper/email copies.","The notice states requests for paper/email copies must be made prior to May 19, 2026.","The notice provides access/request methods: www.ProxyVote.com, call 1-800-579-1639, or email sendmaterial@proxyvote.com (with a control number in the subject line).","The notice states: \u201cTHIS IS NOT A VOTABLE BALLOT\u201d and that it is only an overview of more complete proxy materials."],"numeric_claims":[{"label":"Annual meeting date","value":"June 2, 2026"},{"label":"Request deadline for paper/email copies","value":"May 19, 2026"}],"primary_claim":"Viridian Therapeutics, Inc. filed Form DEFA14A (Schedule 14A information) on 2026-04-17, with proxy materials for a stockholder meeting scheduled for June 2, 2026.","relevance_score":0.45,"sentiment":"neutral","source_quality":"medium","summary":"Viridian Therapeutics, Inc. filed a Schedule 14A proxy-related filing (DEFA14A) providing notice of the availability of proxy materials for a stockholder meeting. The notice states the annual meeting will be held on June 2, 2026 and describes how to access or request the proxy materials.","topics":["SEC filing","proxy statement","Schedule 14A","stockholder meeting notice","proxy materials availability"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form DEFA14A \u00b7 Viridian Therapeutics, Inc.\\DE \u00b7 Filed 20260417","ticker":"VRDN","tickers":["VRDN"],"title":"VRDN filed DEFA14A","url":"https://www.sec.gov/Archives/edgar/data/1590750/0001193125-26-160349.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_87466dad7 {"_evidence_event_ids":["evt_87466dad76c5"]}...
|
signal_enriched:discovery_sec_filing_delta:7d155fe signal_enriched:discovery_sec_filing_delta:7d155fef3e449ce3...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_76b94a0e18a1
|
evt_f83fbc457e29
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1495320/0001628280-26-025831.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1495320/0001628280-26-025831.txt","company":"Vera Bradley, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1495320/0001628280-26-025831.txt","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_df6abe57713f6f37","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1495320/0001628280-26-025831.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:20:04.829247+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"vra-20260417","final_url":"https://www.sec.gov/Archives/edgar/data/1495320/0001628280-26-025831.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1495320/0001628280-26-025831.txt","source_event_id":"evt_16d716dec16a","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"8-K","fp":"adfa311c2a9bbbc7","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2024-10-11","2025-10-10","2026-04-17","2026-04-18"],"entities":[{"asset_class":"equity","name":"Vera Bradley, Inc.","relevance":"high","symbol":"VRA","type":"issuer"},{"asset_class":"other","name":"Equiniti Trust Company, LLC","relevance":"high","symbol":"","type":"rights agent"}],"event_type":"listing","information_gaps":["What changed vs prior known state is only partially evidenced: the text states the amendment advances the Final Expiration Date to April 17, 2026, but the prior Final Expiration Date value is not included in the provided excerpt.","The specific 8-K Item number(s) and whether any exhibits are listed are not provided in the excerpt.","No financial or quantitative impact is disclosed in the provided text beyond termination timing of the Rights Agreement."],"key_facts":["Vera Bradley, Inc. entered into Amendment No. 2 to the Rights Agreement with Equiniti Trust Company, LLC as Rights Agent, dated as of April 17, 2026.","The amendment amends and restates the definition of \u201cFinal Expiration Date\u201d to mean April 17, 2026.","The amendment states its effect is to terminate the Rights Agreement at the Close of Business on the Final Expiration Date in accordance with Sections 7(a) and 7(g) of the Rights Agreement.","The amendment references prior agreements: the original Rights Agreement dated October 11, 2024 and Amendment No. 1 dated October 10, 2025.","The amendment states it is governed by Indiana law for the Company and by New York law for the Rights Agent\u2019s rights, duties, liabilities, and obligations.","The amendment includes a severability clause with a provision that may reinstate the right of redemption if a term is held invalid and the Board determines severing would materially and adversely affect the purpose or effect of the amendment."],"numeric_claims":[{"label":"Final Expiration Date","value":"April 17, 2026"},{"label":"10th Business Day","value":"10th Business Day following the Board determination (as stated in severability clause)"}],"primary_claim":"The company amended the Rights Agreement to set the \u201cFinal Expiration Date\u201d as April 17, 2026, terminating the Rights Agreement at the close of business on that date.","relevance_score":0.45,"sentiment":"neutral","source_quality":"high","summary":"Vera Bradley, Inc. filed an 8-K on April 17, 2026 to amend its shareholder rights agreement. The amendment advances the \u201cFinal Expiration Date\u201d to April 17, 2026, terminating the rights agreement at close of business on that date.","topics":["shareholder rights agreement","rights agreement amendment","Final Expiration Date","corporate governance","8-K filing"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 8-K \u00b7 Vera Bradley, Inc. \u00b7 Filed 20260417","ticker":"VRA","tickers":["VRA"],"title":"VRA filed 8-K","url":"https://www.sec.gov/Archives/edgar/data/1495320/0001628280-26-025831.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_16d716dec {"_evidence_event_ids":["evt_16d716dec16a"]}...
|
signal_enriched:discovery_sec_filing_delta:6bb2a05 signal_enriched:discovery_sec_filing_delta:6bb2a051586f2202...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_6d665e52b96c
|
evt_72c475101790
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1788060/0001628280-26-025842.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1788060/0001628280-26-025842.txt","company":"Voyager Technologies, Inc./DE","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1788060/0001628280-26-025842.txt","article_chars":4999,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_23eba058da672de3","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1788060/0001628280-26-025842.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:20:51.460028+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"voyg-20260417","final_url":"https://www.sec.gov/Archives/edgar/data/1788060/0001628280-26-025842.txt","html_truncated":true,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1788060/0001628280-26-025842.txt","source_event_id":"evt_4261ac69b9ef","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"DEF 14A","fp":"f1f707409024ef61","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.86,"dates_mentioned":["2026-04-17","2026-04-18","2026-05-29","2026-04-01","2029"],"entities":[{"asset_class":"equity","name":"Voyager Technologies, Inc.","relevance":"high","symbol":"VOYG","type":"issuer"},{"asset_class":"regulator","name":"United States Securities and Exchange Commission","relevance":"medium","symbol":"","type":"regulator"},{"asset_class":"service_provider","name":"PricewaterhouseCoopers (PwC)","relevance":"medium","symbol":"","type":"auditor"},{"asset_class":"person","name":"Margaret Vernal","relevance":"medium","symbol":"","type":"officer"}],"event_type":"listing","information_gaps":["What changed vs prior known state is not provided in the signal (no prior filing/version details included).","The identities of the three Class I director nominees are not included in the provided text excerpt.","Details of Proposal 3 (redomestication) beyond the stated Delaware-to-Texas conversion are not included in the provided excerpt.","No amendment number or whether this is an initial DEF 14A vs amended DEF 14A is specified in the provided excerpt (shows \u201c(Amendment No.)\u201d but no number)."],"key_facts":["Form DEF 14A proxy statement filed for Voyager Technologies, Inc. (VOYG).","Annual meeting of stockholders is scheduled for May 29, 2026 at 10:00 a.m. Mountain Time and will be completely virtual via live webcast.","Stockholders can attend online and submit questions during the meeting via www.virtualshareholdermeeting.com/VOYG2026 using a 16-digit control number.","Purposes of the annual meeting include: (1) elect three Class I director nominees until the 2029 annual meeting, (2) ratify PricewaterhouseCoopers as independent registered public accounting firm for the fiscal year ending December 31, 2026, (3) approve redomestication from Delaware to Texas by conversion (Proposal 3), and (4) approve adjournment if necessary to solicit additional proxies if there are not sufficient votes to approve Proposal 3.","Record date to vote: stockholders of record at the close of business on April 1, 2026.","Proxy materials are first distributed or made available on or about April 17, 2026.","The proxy statement is signed/ordered by Margaret Vernal, Chief Legal Officer, General Counsel and Secretary, dated April 17, 2026."],"numeric_claims":[{"label":"Annual meeting date","value":"May 29, 2026"},{"label":"Annual meeting time (Mountain Time)","value":"10:00 a.m."},{"label":"Record date","value":"April 1, 2026"},{"label":"Proxy materials distribution/made available on or about","value":"April 17, 2026"},{"label":"Fiscal year ending","value":"December 31, 2026"}],"primary_claim":"Voyager Technologies, Inc. filed Form DEF 14A (proxy statement) for its annual meeting to be held virtually on May 29, 2026.","relevance_score":0.62,"sentiment":"neutral","source_quality":"high","summary":"Voyager Technologies, Inc. filed a DEF 14A proxy statement for its 2026 annual meeting of stockholders. The filing includes proposals to elect directors, ratify PwC as independent auditor, and approve redomestication from Delaware to Texas.","topics":["SEC filing","proxy statement","annual meeting","director election","independent auditor ratification","redomestication","virtual meeting","stockholder voting"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form DEF 14A \u00b7 Voyager Technologies, Inc./DE \u00b7 Filed 20260417","ticker":"VOYG","tickers":["VOYG"],"title":"VOYG filed DEF 14A","url":"https://www.sec.gov/Archives/edgar/data/1788060/0001628280-26-025842.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_4261ac69b {"_evidence_event_ids":["evt_4261ac69b9ef"]}...
|
signal_enriched:discovery_sec_filing_delta:07bbe2e signal_enriched:discovery_sec_filing_delta:07bbe2e7dd7e6f11...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_acb3532a6c6f
|
evt_d4d3046bc5e2
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1788060/0001628280-26-025855.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1788060/0001628280-26-025855.txt","company":"Voyager Technologies, Inc./DE","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1788060/0001628280-26-025855.txt","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_1961c95943a83612","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1788060/0001628280-26-025855.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:21:01.197892+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"DEFA14A","final_url":"https://www.sec.gov/Archives/edgar/data/1788060/0001628280-26-025855.txt","html_truncated":true,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1788060/0001628280-26-025855.txt","source_event_id":"evt_5bf7eac246e0","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"DEFA14A","fp":"edc7bd8e494e3925","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-17","2026-05-28","2026-05-29","2019-09-12"],"entities":[{"asset_class":"equity","name":"Voyager Technologies, Inc./DE","relevance":"primary","symbol":"VOYG","type":"issuer"},{"asset_class":"regulation","name":"U.S. Securities and Exchange Commission","relevance":"context","symbol":"","type":"regulator"},{"asset_class":"service_provider","name":"PricewaterhouseCoopers LLP","relevance":"secondary","symbol":"","type":"auditor"}],"event_type":"listing","information_gaps":["What specifically changed versus the prior known state is not provided in the signal text (no prior filing comparison content included).","The \u201c(Amendment No.)\u201d value is not shown in the provided excerpt.","No financial guidance or financial implications are disclosed in the provided text beyond proxy voting items.","No details are provided about the rationale, mechanics, or expected effects of the redomestication from Delaware to Texas beyond the proposal title."],"key_facts":["SEC filing type: DEFA14A (Definitive Additional Materials)","Filed as of date: 2026-04-17; accession number: 0001628280-26-025855","The filing is a Schedule 14A information/proxy statement pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. not specified in provided text)","Annual meeting notice: stockholder meeting to be held May 29, 2026; virtual meeting time shown as 10:00 a.m. MT","Vote deadline shown: May 28, 2026 at 11:59 PM ET","Proposal 1: elect three Class I directors (nominees listed: Gabe Finke, Marian Joh, Matthew Kuta) to serve until the 2029 annual meeting","Proposal 2: ratify appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year ending December 31, 2026","Proposal 3: approve redomestication of the Company from Delaware to Texas","Proposal 4: approve adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes to approve Proposal 3","The filing states: \u201cTHIS IS NOT A VOTABLE BALLOT\u201d and provides instructions to vote via ProxyVote.com and a virtual meeting website"],"numeric_claims":[{"label":"Annual meeting date","value":"May 29, 2026"},{"label":"Virtual meeting time (MT)","value":"10:00 a.m. MT"},{"label":"Vote deadline (ET)","value":"May 28, 2026 11:59 PM ET"},{"label":"Number of directors to elect","value":"3"},{"label":"Director class","value":"Class I"},{"label":"Director term end","value":"until the 2029 annual meeting"},{"label":"Fiscal year end for auditor ratification","value":"December 31, 2026"}],"primary_claim":"Voyager Technologies, Inc./DE filed Form DEFA14A (definitive additional materials) on 2026-04-17 for its 2026 annual meeting proxy materials.","relevance_score":0.55,"sentiment":"neutral","source_quality":"high","summary":"Voyager Technologies, Inc./DE filed a definitive additional proxy materials filing (DEFA14A) with the SEC on April 17, 2026. The filing provides notice of the 2026 annual meeting and outlines vote items including director elections, auditor ratification, and a redomestication proposal.","topics":["SEC filing","proxy statement","annual meeting","director election","independent auditor","redomestication","adjournment"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form DEFA14A \u00b7 Voyager Technologies, Inc./DE \u00b7 Filed 20260417","ticker":"VOYG","tickers":["VOYG"],"title":"VOYG filed DEFA14A","url":"https://www.sec.gov/Archives/edgar/data/1788060/0001628280-26-025855.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_5bf7eac24 {"_evidence_event_ids":["evt_5bf7eac246e0"]}...
|
signal_enriched:discovery_sec_filing_delta:f665907 signal_enriched:discovery_sec_filing_delta:f6659079fb6944fa...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_80f665da4d61
|
evt_5e9c79ea5691
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/93314/0001477932-26-002373.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/93314/0001477932-26-002373.txt","company":"VOLITIONRX LTD","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/93314/0001477932-26-002373.txt","article_chars":3919,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_ced9feae28103bdc","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/93314/0001477932-26-002373.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:21:06.602504+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"vnrx_8k.htm","final_url":"https://www.sec.gov/Archives/edgar/data/93314/0001477932-26-002373.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/93314/0001477932-26-002373.txt","source_event_id":"evt_bb59d8f988d1","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"8-K","fp":"2fd015a023662161","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.86,"dates_mentioned":["2026-04-17","2026-04-18","2026-04-01","2026-03-31","2026-04-28","2026-01-15","2025-05-20"],"entities":[{"asset_class":"equity","name":"VolitionRx Limited","relevance":"primary","symbol":"","type":"issuer"},{"asset_class":"other","name":"Lind Global Asset Management XII LLC","relevance":"secondary","symbol":"","type":"counterparty"}],"event_type":"listing","information_gaps":["The filing\u2019s SEC \u201cItem\u201d number is stated as Item 8.01 (Other Events), but no additional financial guidance or quantitative financial impact is provided in the provided text.","The specific approved range of reverse split ratios from the April 1, 2026 disclosure is not included in the provided text.","No ticker symbol for VolitionRx Limited is provided in the text, so a standardized tradable symbol cannot be populated."],"key_facts":["The company previously disclosed shareholder approval (under Item 5.07 of an 8-K filed April 1, 2026) for the board to exercise discretion to amend the Second Amended and Restated Certificate of Incorporation to effect a reverse stock split with a ratio within an approved range.","The board approved the reverse stock split at a ratio of one-for-twenty (1-for-20) (the \u201cSplit Ratio\u201d).","The reverse stock split is being effected in consideration of terms of documents executed in connection with financings with Lind Global Asset Management XII LLC consummated on May 20, 2025 and January 15, 2026.","The reverse stock split is expected to become effective at 12:01 a.m. ET on April 28, 2026 (the \u201cEffective Date\u201d).","Shares are expected to begin trading on a split-adjusted basis at market open.","As of the Effective Date, every 20 shares of common stock will be automatically converted into one share of common stock.","No fractional shares will be issued; holders entitled to fractional shares will receive one whole share in lieu of fractional shares.","Outstanding warrants, options, equity incentive awards, and other outstanding equity securities and instruments will be rounded up to the next whole share or, if applicable, cash will be paid in lieu of fractional shares per their terms.","Proportionate adjustments will be made (per the Split Ratio) to: (i) outstanding equity incentive awards under the 2015 Stock Incentive Plan and 2024 Stock Incentive Plan, (ii) outstanding warrants and convertible notes, (iii) shares of common stock available for future issuance under the 2024 Stock Incentive Plan, and (iv) other outstanding equity securities and instruments."],"numeric_claims":[{"label":"Reverse stock split ratio","value":"1-for-20"},{"label":"Effective time","value":"12:01 a.m. ET"},{"label":"Effective date","value":"2026-04-28"},{"label":"Conversion rule","value":"20 shares -> 1 share"},{"label":"Rounding rule","value":"fractional shares rounded up to next whole share; cash may be paid in lieu per instrument terms"}],"primary_claim":"The board approved a reverse stock split of VolitionRx Limited\u2019s common stock at a ratio of one-for-twenty (1-for-20), expected to become effective at 12:01 a.m. ET on April 28, 2026.","relevance_score":0.62,"sentiment":"neutral","source_quality":"high","summary":"VolitionRx Limited filed an 8-K to announce that its board approved and the company is effecting a 1-for-20 reverse stock split of its common stock. The split is expected to become effective April 28, 2026 and will adjust outstanding equity awards and instruments proportionately.","topics":["reverse stock split","common stock","share conversion","equity award adjustments","warrants and convertible notes","SEC 8-K","corporate actions"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 8-K \u00b7 VOLITIONRX LTD \u00b7 Filed 20260417","ticker":"VNRX","tickers":["VNRX"],"title":"VNRX filed 8-K","url":"https://www.sec.gov/Archives/edgar/data/93314/0001477932-26-002373.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_bb59d8f98 {"_evidence_event_ids":["evt_bb59d8f988d1"]}...
|
signal_enriched:discovery_sec_filing_delta:13825af signal_enriched:discovery_sec_filing_delta:13825af01a2945b7...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_1830f6abc1fe
|
evt_0e0266b17490
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1520504/0001292814-26-002416.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1520504/0001292814-26-002416.txt","company":"Controladora Vuela Compania de Aviacion, S.A.B. de C.V.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1520504/0001292814-26-002416.txt","article_chars":4999,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_ef70d848df0efd52","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1520504/0001292814-26-002416.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:21:12.524843+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1520504/0001292814-26-002416.txt","html_truncated":true,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1520504/0001292814-26-002416.txt","source_event_id":"evt_619a4204a9ea","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"6-K","fp":"110fb3caf89dcda5","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-17","2026-04-18","2026-04","2026-03-25","March 2006"],"entities":[{"asset_class":"equity","name":"Controladora Vuela Compa\u00f1\u00eda de Aviaci\u00f3n, S.A.B. de C.V.","relevance":"high","symbol":"VLRS","type":"issuer"},{"asset_class":"equity","name":"Volaris","relevance":"high","symbol":"VLRS","type":"company"},{"asset_class":"other","name":"Extraordinary General Shareholders\u2019 Meeting","relevance":"high","symbol":"","type":"corporate_event"},{"asset_class":"other","name":"Ley del Mercado de Valores (Mexican Securities Market Law)","relevance":"medium","symbol":"","type":"legal_regulation"},{"asset_class":"other","name":"NYSE","relevance":"medium","symbol":"VLRS","type":"exchange"},{"asset_class":"other","name":"BMV","relevance":"low","symbol":"VOLAR","type":"exchange"}],"event_type":"listing","information_gaps":["What specific text changes were made to Clause Eight (beyond the described scope exclusion) is not provided in the excerpt.","The Form 6-K filing timestamp in the provided context is 2026-04-18T03:05:05.644967+00:00, but the SEC filing date is not explicitly stated in the document text excerpt itself.","No prior known state (e.g., the previous bylaws language) is included in the provided text, so the exact delta versus prior bylaws cannot be fully verified beyond the described change-of-control scope."],"key_facts":["The SEC filing is a Form 6-K for the month of April 2026.","The registrant is Controladora Vuela Compa\u00f1\u00eda de Aviaci\u00f3n, S.A.B. de C.V. (NYSE: VLRS).","The Form 6-K includes an explanatory note stating that on April 17, 2026 the company issued a press release titled \u201cVolaris amends its bylaws in accordance with the resolutions approved by the Extraordinary General Shareholders\u2019 Meeting held on March 25, 2026.\u201d","The press release is attached as Exhibit 99.1; an English translation of amended and restated bylaws is attached as Exhibit 99.2.","According to the press release, shareholders approved amendments to the company\u2019s bylaws by a majority vote of shareholders in attendance at the Extraordinary General Shareholders\u2019 Meeting held on March 25, 2026.","The press release states the amendments (i) align the bylaws with the latest amendments to the Mexican Securities Market Law (Ley del Mercado de Valores).","The press release states the amendments provide that the change of control provisions in Clause Eight will not apply to acquisitions/transfers of shares, or any agreement/arrangement, by a person acquiring shares as a result of a merger where the company is the surviving entity."],"numeric_claims":[{"label":"Majority vote of shareholders in attendance","value":"majority (no numeric percentage provided)"}],"primary_claim":"On March 25, 2026, shareholders approved amendments to Volaris\u2019 bylaws, and the company reported this via a Form 6-K filed with the SEC on April 18, 2026 (press release dated April 17, 2026; bylaws translation attached).","relevance_score":0.62,"sentiment":"neutral","source_quality":"high","summary":"Controladora Vuela Compa\u00f1\u00eda de Aviaci\u00f3n, S.A.B. de C.V. (NYSE: VLRS) filed a Form 6-K on April 18, 2026 to report that it issued a press release on April 17, 2026 regarding amendments to its bylaws approved by shareholders on March 25, 2026. The amendments include aligning the bylaws with updates to Mexico\u2019s Securities Market Law and modifying change-of-control provisions for certain merger-related share acquisitions/transfers.","topics":["SEC filing","Form 6-K","bylaws amendments","shareholder approval","Mexican Securities Market Law alignment","change of control provisions","merger-related share acquisitions/transfers"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 6-K \u00b7 Controladora Vuela Compania de Aviacion, S.A.B. de C.V. \u00b7 Filed 20260417","ticker":"VLRS","tickers":["VLRS"],"title":"VLRS filed 6-K","url":"https://www.sec.gov/Archives/edgar/data/1520504/0001292814-26-002416.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_619a4204a {"_evidence_event_ids":["evt_619a4204a9ea"]}...
|
signal_enriched:discovery_sec_filing_delta:df651d7 signal_enriched:discovery_sec_filing_delta:df651d7519813933...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_40c5f23d09de
|
evt_4b9eae5123d9
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1863006/0001976408-26-000345.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1863006/0001976408-26-000345.txt","company":"Valens Semiconductor Ltd.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1863006/0001976408-26-000345.txt","article_chars":1713,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_885f3477e35fb40a","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1863006/0001976408-26-000345.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:21:19.510444+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1863006/0001976408-26-000345.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1863006/0001976408-26-000345.txt","source_event_id":"evt_c4865e3a9087","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"144","fp":"ffaf7d3f038d183e","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.72,"dates_mentioned":["2026-04-17","2026-04-16","2026-01-15","2026-01-20","2026-03-30"],"entities":[{"asset_class":"equity","name":"Valens Semiconductor Ltd.","relevance":"high","symbol":"","type":"issuer"},{"asset_class":"equity","name":"Yaacobi Tal","relevance":"high","symbol":"","type":"reporting_owner"},{"asset_class":"equity","name":"Oppenheimer & Co. Inc.","relevance":"medium","symbol":"","type":"broker_or_intermediary"}],"event_type":"listing","information_gaps":["The text does not explicitly state the total number of shares to be sold across all lines in a single consolidated field; only line-level quantities/prices are shown.","The filing\u2019s purpose (e.g., sale vs transfer) is not explicitly described in the provided excerpt beyond the Form 144 context.","No prior known state is provided in the prompt, so the 'delta vs prior' change cannot be determined from the supplied information alone."],"key_facts":["SEC accession number: 0001976408-26-000345.","Conformed submission type: Form 144.","Filed as of date: 2026-04-17 (DATE AS OF CHANGE: 2026-04-17).","Subject company: Valens Semiconductor Ltd. (CIK: 0001863006; SEC file number: 001-40842).","Reporting owner: Yaacobi Tal (Director; address listed as non-US).","The filing references Restricted Stock Units with a date shown as 01/15/2026 and an additional date shown as 01/20/2026.","The filing includes ordinary share quantities and prices: 2050 shares at 3915.50; 1400 shares at 1554.00; and a line item showing 3750 shares at 5512.50 (dates shown include 04/16/2026 and 03/30/2026).","A broker/intermediary name appears: Oppenheimer & Co. Inc. (85 Broad St., New York, NY 10004)."],"numeric_claims":[{"label":"shares_quantity_line_1","value":"3750"},{"label":"shares_price_line_1","value":"5512.50"},{"label":"shares_quantity_line_2","value":"2050"},{"label":"shares_price_line_2","value":"3915.50"},{"label":"shares_quantity_line_3","value":"1400"},{"label":"shares_price_line_3","value":"1554.00"},{"label":"restricted_stock_units_date_shown","value":"01/15/2026"},{"label":"ordinary_shares_date_shown_1","value":"04/16/2026"},{"label":"ordinary_shares_date_shown_2","value":"01/20/2026"},{"label":"ordinary_shares_date_shown_3","value":"03/30/2026"}],"primary_claim":"On 2026-04-17, Valens Semiconductor Ltd. filed SEC Form 144 (accession 0001976408-26-000345).","relevance_score":0.45,"sentiment":"neutral","source_quality":"medium","summary":"Valens Semiconductor Ltd. filed a Form 144 on 2026-04-17. The filing relates to reported sales/transfer activity by reporting owner Yaacobi Tal involving restricted stock units and ordinary shares.","topics":["SEC Form 144","insider/affiliate sale notice","restricted stock units","ordinary shares","Valens Semiconductor Ltd."]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 144 \u00b7 Valens Semiconductor Ltd. \u00b7 Filed 20260417","ticker":"VLN","tickers":["VLN"],"title":"VLN filed 144","url":"https://www.sec.gov/Archives/edgar/data/1863006/0001976408-26-000345.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_c4865e3a9 {"_evidence_event_ids":["evt_c4865e3a9087"]}...
|
signal_enriched:discovery_sec_filing_delta:d58edf0 signal_enriched:discovery_sec_filing_delta:d58edf0e0b6fd699...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_bbd3e4436c87
|
evt_6217f9a19241
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1826286/0000950103-26-005898.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1826286/0000950103-26-005898.txt","company":"Vinci Compass Investments Ltd.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1826286/0000950103-26-005898.txt","article_chars":2831,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_b743c3b7b369728b","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1826286/0000950103-26-005898.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:21:34.728202+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1826286/0000950103-26-005898.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1826286/0000950103-26-005898.txt","source_event_id":"evt_276e390958da","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"17d0ce60c0121acd","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-17","2026-04-15","2026-04-16","2025-12-19","2020-09-28"],"entities":[{"asset_class":"equity","name":"Vinci Compass Investments Ltd.","relevance":"high","symbol":"VINP","type":"issuer"},{"asset_class":"equity","name":"Bruno Augusto Sacchi Zaremba","relevance":"high","symbol":"","type":"reporting_owner"},{"asset_class":"equity","name":"Pico da Neblina Ltd.","relevance":"medium","symbol":"","type":"plan_execution_entity"},{"asset_class":"equity","name":"Julya Sotto Mayor Wellisch","relevance":"low","symbol":"","type":"attorney_in_fact"}],"event_type":"listing","information_gaps":["The text provided does not include the exact number of shares sold in each transaction (only partial numeric fields appear, but they are not clearly mapped to share counts in the excerpt).","The excerpt does not explicitly state whether the transactions were purchases or sales beyond the statement that the sale reported on the Form 4 was effected under the Rule 10b5-1 plan.","No prior known state is included in the prompt, so the specific 'delta vs prior' change cannot be determined from the provided text alone."],"key_facts":["SEC filing is Form 4 (conformed submission type: 4).","Issuer: Vinci Compass Investments Ltd. (SEC file number 001-39938; SIC 6282).","Reporting person: Bruno Augusto Sacchi Zaremba (central index key 0002028300).","Form 4 period of report (conformed): 20260415; filed as of date: 20260417.","The sale(s) were effected pursuant to a Rule 10b5-1 trading plan adopted on December 19, 2025.","The price reported is a weighted average price.","One set of sales lists sale prices ranging from $10.50 to $10.85 (inclusive) (footnote (2) referenced).","Another set of sales lists sale prices ranging from $10.78 to $11.12 (inclusive) (footnote (3) referenced).","The reporting person states shares were sold in multiple transactions at prices within the stated ranges.","The reporting person undertakes to provide full information regarding the number of shares sold at each separate price within the ranges upon request.","Signature: /s/ Julya Sotto Mayor Wellisch, as Attorney-in-Fact for Bruno Augusto Sacchi Zaremba; dated 2026-04-17."],"numeric_claims":[{"label":"Rule 10b5-1 plan adoption date","value":"2025-12-19"},{"label":"Filing date (filed as of date)","value":"2026-04-17"},{"label":"Conformed period of report","value":"2026-04-15"},{"label":"Sale price range (inclusive) - footnote (2)","value":"$10.50 to $10.85"},{"label":"Sale price range (inclusive) - footnote (3)","value":"$10.78 to $11.12"}],"primary_claim":"Form 4 filed on 2026-04-17 reports sales of Vinci Compass Investments Ltd. Class A Common Shares by Bruno Augusto Sacchi Zaremba under a Rule 10b5-1 plan adopted December 19, 2025.","relevance_score":0.62,"sentiment":"neutral","source_quality":"high","summary":"Vinci Compass Investments Ltd. (VINP) disclosed on Form 4 that reporting person Bruno Augusto Sacchi Zaremba sold Class A Common Shares on 2026-04-15 and 2026-04-16. The sales were executed under a Rule 10b5-1 trading plan adopted on December 19, 2025, with weighted-average prices and ranges of sale prices.","topics":["SEC Form 4","insider trading","Rule 10b5-1 trading plan","Class A Common Shares","weighted average price","share sales"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 Vinci Compass Investments Ltd. \u00b7 Filed 20260417","ticker":"VINP","tickers":["VINP"],"title":"VINP filed 4","url":"https://www.sec.gov/Archives/edgar/data/1826286/0000950103-26-005898.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_276e39095 {"_evidence_event_ids":["evt_276e390958da"]}...
|
signal_enriched:discovery_sec_filing_delta:0433169 signal_enriched:discovery_sec_filing_delta:04331697679db196...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_12199e303405
|
evt_06a33d42b4b3
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1826286/0000950103-26-005899.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1826286/0000950103-26-005899.txt","company":"Vinci Compass Investments Ltd.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1826286/0000950103-26-005899.txt","article_chars":2790,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_d0d6297ef047d7a0","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1826286/0000950103-26-005899.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:21:43.096149+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1826286/0000950103-26-005899.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1826286/0000950103-26-005899.txt","source_event_id":"evt_cf7cf7cfdae6","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"8b7a96c1b108ade8","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-17","2026-04-15","2025-12-15","2020-09-28"],"entities":[{"asset_class":"equity","name":"Vinci Compass Investments Ltd.","relevance":"high","symbol":"VINP","type":"issuer"},{"asset_class":"equity","name":"Fernando Lovisotto","relevance":"high","symbol":"","type":"reporting_person"},{"asset_class":"equity","name":"Dolomita Capital Ltd.","relevance":"medium","symbol":"","type":"agent"}],"event_type":"listing","information_gaps":["The exact number of shares sold in each transaction is not fully captured in the provided cleaned text (only partial numeric fragments like '7198' and '7551' appear without clear mapping to each transaction).","The prior known state (what changed vs prior filings) is not provided, so the delta cannot be determined beyond the fact that this Form 4 was filed.","No explicit total shares sold or total proceeds are clearly stated in the provided text excerpt."],"key_facts":["SEC filing: Form 4 (conformed submission type: 4) filed as of 2026-04-17.","Issuer: Vinci Compass Investments Ltd. (CIK 0001826286).","Reporting person: Fernando Lovisotto (CIK 0002028299).","Transaction period/conformed period of report: 20260415.","The sale(s) were effected pursuant to a Rule 10b5-1 trading plan adopted on December 15, 2025.","The price reported is a weighted average price.","Shares were sold in multiple transactions with prices ranging from $10.40 to $10.84 (inclusive) (footnote (2) range).","The reporting person undertakes to provide full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) upon request.","Additional disclosed price range: $10.65 to $11.16 (inclusive) (footnote (3) range).","The reporting person undertakes to provide full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) upon request.","Signature: /s/ Julya Sotto Mayor Wellisch, as Attorney-in-Fact for Fernando Lovisotto.","Form 4 accession number: 0000950103-26-005899."],"numeric_claims":[{"label":"Filing date (as of)","value":"2026-04-17"},{"label":"Conformed period of report","value":"2026-04-15"},{"label":"Rule 10b5-1 plan adoption date","value":"2025-12-15"},{"label":"Price range (footnote 2)","value":"$10.40-$10.84"},{"label":"Price range (footnote 3)","value":"$10.65-$11.16"}],"primary_claim":"Fernando Lovisotto sold Vinci Compass Investments Ltd. Class A common shares on 2026-04-15 under a Rule 10b5-1 trading plan adopted December 15, 2025, as reported in Form 4 filed on 2026-04-17.","relevance_score":0.62,"sentiment":"neutral","source_quality":"high","summary":"Vinci Compass Investments Ltd. (VINP) reported on Form 4 that reporting person Fernando Lovisotto sold Class A common shares on 2026-04-15. The sales were executed under a Rule 10b5-1 trading plan adopted on December 15, 2025, with weighted-average prices and multiple transaction price ranges disclosed.","topics":["SEC Form 4","insider trading","Rule 10b5-1 trading plan","share sale","weighted average price","Class A common shares"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 Vinci Compass Investments Ltd. \u00b7 Filed 20260417","ticker":"VINP","tickers":["VINP"],"title":"VINP filed 4","url":"https://www.sec.gov/Archives/edgar/data/1826286/0000950103-26-005899.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_cf7cf7cfd {"_evidence_event_ids":["evt_cf7cf7cfdae6"]}...
|
signal_enriched:discovery_sec_filing_delta:c4dd9c0 signal_enriched:discovery_sec_filing_delta:c4dd9c0c14374595...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_dd78e67acbe4
|
evt_d79700fa1384
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/751978/0000901484-26-000008.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/751978/0000901484-26-000008.txt","company":"VICOR CORP","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/751978/0000901484-26-000008.txt","article_chars":2837,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_1eb35a10c30478d1","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/751978/0000901484-26-000008.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:21:50.927273+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/751978/0000901484-26-000008.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/751978/0000901484-26-000008.txt","source_event_id":"evt_932e383f7460","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"15d2ea8f0211a1f8","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-17","2026-04-16","2025-11-03","2012-12-21"],"entities":[{"asset_class":"equity","name":"VICOR CORP","relevance":"high","symbol":"VICR","type":"issuer"},{"asset_class":"equity","name":"Patrizio Vinciarelli","relevance":"high","symbol":"","type":"reporting_person"},{"asset_class":"equity","name":"Patrizio Vinciarelli Irrevocable Trust U/A Dated 12/21/2012","relevance":"medium","symbol":"","type":"trust"}],"event_type":"listing","information_gaps":["The provided text does not include the full table structure (e.g., exact share counts per row) beyond the presence of quantities/prices in the snippet; therefore total shares sold and total proceeds cannot be reliably computed from the excerpt.","The signal is labeled discovery_sec_filing_delta, but no prior known state (previous filing or earlier holdings) is included in the provided text, so the 'what changed vs prior' cannot be determined.","The excerpt does not explicitly state whether the Form 4 includes only sales (it appears to, but the exact transaction type per row is not fully shown)."],"key_facts":["SEC filing: Form 4 for VICOR CORP filed as of 2026-04-17 (accession number 0000901484-26-000008).","Conformed period of report: 2026-04-16.","Reporting person: Patrizio Vinciarelli, identified as Chairman and CEO.","Security: Common Stock (footnote text indicates shares are held as Trustee of the Patrizio Vinciarelli Irrevocable Trust U/A Dated 12/21/2012).","The filing states the sale was effected pursuant to a Rule 10b5-1 trading plan adopted on 2025-11-03.","The filing reports multiple sale transactions with weighted average prices shown in the table (e.g., 196.109; 197.0001; 198.0829; 199.0703; 196.109 and other weighted averages appear in the provided text).","The filing includes sale price ranges across multiple transactions (ranges explicitly shown include $196.0000\u2013$196.8900, $197.0000\u2013$197.1600, $198.0000\u2013$198.6000, $199.0000\u2013$199.8600).","The filing includes an undertaking to provide full information on the number of shares sold at each separate price within the ranges upon request."],"numeric_claims":[{"label":"Weighted average price (example shown)","value":"196.109"},{"label":"Weighted average price (example shown)","value":"197.0001"},{"label":"Weighted average price (example shown)","value":"198.0829"},{"label":"Weighted average price (example shown)","value":"199.0703"},{"label":"Rule 10b5-1 plan adoption date","value":"2025-11-03"},{"label":"Conformed period of report (sale date)","value":"2026-04-16"}],"primary_claim":"On 2026-04-16, Patrizio Vinciarelli (Chairman and CEO of Vicor Corp) sold shares of Vicor common stock under a Rule 10b5-1 trading plan adopted November 3, 2025, as disclosed in a Form 4 filed April 17, 2026.","relevance_score":0.62,"sentiment":"neutral","source_quality":"high","summary":"VICOR CORP reported a Form 4 filed on 2026-04-17 covering sales of VICOR common stock by reporting person Patrizio Vinciarelli (Chairman and CEO). The filing states the sales were executed under a Rule 10b5-1 trading plan adopted on 2025-11-03 and provides weighted-average prices and sale price ranges.","topics":["SEC Form 4","insider trading","Rule 10b5-1 trading plan","common stock sales","weighted average price","share sale price ranges"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 VICOR CORP \u00b7 Filed 20260417","ticker":"VICR","tickers":["VICR"],"title":"VICR filed 4","url":"https://www.sec.gov/Archives/edgar/data/751978/0000901484-26-000008.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_932e383f7 {"_evidence_event_ids":["evt_932e383f7460"]}...
|
signal_enriched:discovery_sec_filing_delta:fbdc57e signal_enriched:discovery_sec_filing_delta:fbdc57ef44af9f84...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_bb0f76f0c1ba
|
evt_476f2e47f32b
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1692376/0001214659-26-004819.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1692376/0001214659-26-004819.txt","company":"Velocity Financial, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1692376/0001214659-26-004819.txt","article_chars":2026,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_36970e8a84a22184","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1692376/0001214659-26-004819.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:22:14.033158+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1692376/0001214659-26-004819.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1692376/0001214659-26-004819.txt","source_event_id":"evt_d31dbc3b5a7c","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"6af9290302c68633","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.72,"dates_mentioned":["2026-04-17"],"entities":[{"asset_class":"equity","name":"Velocity Financial, Inc.","relevance":"high","symbol":"VEL","type":"issuer"},{"asset_class":"equity","name":"Taylor Jeffrey T.","relevance":"high","symbol":"","type":"reporting_person"},{"asset_class":"equity","name":"Roland T. Kelly","relevance":"medium","symbol":"","type":"signatory"}],"event_type":"other","information_gaps":["What changed vs prior known state is not provided in the signal (no prior Form 4/transaction details included).","The filing text excerpt does not explicitly state whether the transaction was a sale only vs any other transaction types beyond the described sale price/shares sold.","No disclosure of total proceeds, remaining holdings, or whether there were multiple separate transactions beyond the price range statement."],"key_facts":["SEC filing type: Form 4 (SEC Act: 1934 Act).","Issuer: Velocity Financial, Inc. (VEL).","Reporting person: Taylor Jeffrey T., listed as Executive VP, Capital Markets.","Transaction date/period of report: 2026-04-17.","Security: Common Stock.","Shares sold: 2,130.","Sale price: $20.00 (weighted average; footnote indicates shares sold in multiple transactions at prices ranging from $20.00 to $20.00).","Undertaking: reporting person undertakes to provide full information regarding number of shares sold at each separate price within the ranges upon request."],"numeric_claims":[{"label":"shares_sold","value":"2130"},{"label":"weighted_average_sale_price_usd","value":"20.00"},{"label":"price_range_low_usd","value":"20.00"},{"label":"price_range_high_usd","value":"20.00"}],"primary_claim":"On 2026-04-17, Velocity Financial, Inc. filed Form 4 reporting that Taylor Jeffrey T. (Executive VP, Capital Markets) sold 2,130 shares of Velocity Financial, Inc. common stock at a weighted-average price of $20.00.","relevance_score":0.45,"sentiment":"neutral","source_quality":"medium","summary":"Velocity Financial, Inc. (VEL) filed a Form 4 on 2026-04-17 disclosing sales of common stock by executive officer Taylor Jeffrey T. The filing reports a weighted-average sale price of $20.00 for 2,130 shares, with transactions occurring at $20.00.","topics":["SEC Form 4","insider trading","common stock sale","weighted-average price","executive officer transaction"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 Velocity Financial, Inc. \u00b7 Filed 20260417","ticker":"VEL","tickers":["VEL"],"title":"VEL filed 4","url":"https://www.sec.gov/Archives/edgar/data/1692376/0001214659-26-004819.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_d31dbc3b5 {"_evidence_event_ids":["evt_d31dbc3b5a7c"]}...
|
signal_enriched:discovery_sec_filing_delta:884503d signal_enriched:discovery_sec_filing_delta:884503d45743d439...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_db1b19ce6651
|
evt_653f67377bd9
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1867090/0001974158-26-000056.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1867090/0001974158-26-000056.txt","company":"Fundrise Innovation Fund, LLC","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1867090/0001974158-26-000056.txt","article_chars":4212,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_622e29a355e57a7c","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1867090/0001974158-26-000056.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:22:20.213001+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1867090/0001974158-26-000056.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1867090/0001974158-26-000056.txt","source_event_id":"evt_fa890fd83e5f","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"144","fp":"875e2a44974d5b34","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-17","2026-02-24","2026-03-25","2026-03-26","2026-03-27","2026-03-30","2026-03-31","2026-04-01","2026-04-02","2026-04-06","2026-04-07","2026-04-08","2026-04-09","2026-04-10","2026-04-13","2026-04-14","2026-04-15","2026-04-16","2026-04-17","2022-02-18","2021-06-11","2019-05-23","2026-04-18T03:05:05.644967+00:00"],"entities":[{"asset_class":"equity_fund","name":"Fundrise Innovation Fund, LLC","relevance":"high","symbol":"","type":"issuer_or_reporting_owner"},{"asset_class":"equity_reit","name":"TECH INFRASTRUCTURE REIT, LLC","relevance":"high","symbol":"","type":"subsidiary_or_related_entity"},{"asset_class":"equity_fund","name":"Fundrise Real Estate Interval Fund, LLC","relevance":"medium","symbol":"","type":"related_entity"},{"asset_class":"broker","name":"Common Jefferies LLC","relevance":"low","symbol":"","type":"broker_or_other"}],"event_type":"listing","information_gaps":["The signal is labeled \u201cVCX filed 144,\u201d but the provided text does not mention \u201cVCX\u201d; the issuer/reporting owner shown is Fundrise Innovation Fund, LLC.","The filing text excerpt does not clearly label the meaning of numeric columns (e.g., quantities/prices) beyond showing multiple dated transaction lines; exact interpretation is uncertain.","No explicit \u201cwhat changed vs prior known state\u201d is provided in the input; only the new filing details are available.","No explicit guidance or financial implication language (e.g., expected proceeds, risk factors) is included in the provided excerpt."],"key_facts":["Filing: Form 144 (SEC Act: 1933 Act)","Filed as of date: 2026-04-17","Accession number: 0001974158-26-000056","Subject company: Fundrise Innovation Fund, LLC (Central Index Key: 0001867090)","Reporting owner includes Fundrise Innovation Fund, LLC (Central Index Key: 0001867090)","Filing values include SEC file number 811-23708 and business address at 11 Dupont Circle NW, 9th Floor, Washington, DC 20036","The filing includes multiple rows of transactions with dates from 02/24/2026 through 04/17/2026","One line states: \u201cShares to be sold from TECH INFRASTRUCTURE REIT, LLC a wholly-owned subsidiary of Fundrise Real Estate Interval Fund, LLC.\u201d","Broker/other listed: Common Jefferies LLC, 520 Madison Ave 4th Fl, New York, NY 10022"],"numeric_claims":[{"label":"Number of public documents","value":"1"},{"label":"NYSE common (as shown in filing values)","value":"Common"},{"label":"First transaction date shown","value":"02/24/2026"},{"label":"Last transaction date shown","value":"04/17/2026"}],"primary_claim":"On 2026-04-17, Fundrise Innovation Fund, LLC filed Form 144 (SEC Act of 1933) under accession number 0001974158-26-000056.","relevance_score":0.45,"sentiment":"neutral","source_quality":"high","summary":"Fundrise Innovation Fund, LLC filed a Form 144 on 2026-04-17. The filing lists multiple sale transactions dated 2026-02-24 through 2026-04-17 for shares associated with TECH INFRASTRUCTURE REIT, LLC.","topics":["SEC Form 144","share sales","registered offering on Form N-2","Fundrise funds","TECH INFRASTRUCTURE REIT, LLC"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 144 \u00b7 Fundrise Innovation Fund, LLC \u00b7 Filed 20260417","ticker":"VCX","tickers":["VCX"],"title":"VCX filed 144","url":"https://www.sec.gov/Archives/edgar/data/1867090/0001974158-26-000056.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_fa890fd83 {"_evidence_event_ids":["evt_fa890fd83e5f"]}...
|
signal_enriched:discovery_sec_filing_delta:c777eca signal_enriched:discovery_sec_filing_delta:c777eca42589f361...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_1bae6be3f3ad
|
evt_086b4f9be37f
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1812286/0001306763-26-000001.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1812286/0001306763-26-000001.txt","company":"Harrison Street Infrastructure Income Fund","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1812286/0001306763-26-000001.txt","article_chars":1570,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_d3e39ab7554c8fe3","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1812286/0001306763-26-000001.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:22:24.487999+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1812286/0001306763-26-000001.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1812286/0001306763-26-000001.txt","source_event_id":"evt_66dca01bcd7e","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"8f26e1182da2a5a0","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.7,"dates_mentioned":["2026-04-16","2026-04-17","2021-12-20","2020-05-15"],"entities":[{"asset_class":"fund","name":"Harrison Street Infrastructure Income Fund","relevance":"high","symbol":"","type":"issuer"},{"asset_class":"person","name":"Richard J. McCready","relevance":"high","symbol":"","type":"reporting_owner"},{"asset_class":"person","name":"Kelly Bolduc","relevance":"medium","symbol":"","type":"signatory"}],"event_type":"listing","information_gaps":["The specific insider transaction details (e.g., security name/ticker, number of shares, price, transaction type) are not present in the provided cleaned text excerpt.","The signal is labeled as a 'discovery_sec_filing_delta', but no prior known state or comparison content is included, so 'what changed vs prior' cannot be determined from the provided text only.","The excerpt includes a numeric value '19743.337' and '10.13' but does not provide labels for what these numbers represent (e.g., shares vs. price vs. value).","No explicit guidance/financial implication is stated in the provided text."],"key_facts":["SEC accession number: 0001306763-26-000001.","Conformed submission type: 4 (Form 4).","Conformed period of report: 20260416.","Filed as of date: 20260417.","Reporting owner: Richard J. McCready.","Signature line indicates: /s/ Kelly Bolduc, by power of attorney.","Issuer name shown: Harrison Street Infrastructure Income Fund (CIK 0001812286).","Issuer former names listed: Versus Capital Infrastructure Income Fund (name change 2021-12-20) and Versus Capital Real Asset Debt Fund (name change 2020-05-15)."],"numeric_claims":[{"label":"reporting_period","value":"20260416"},{"label":"filed_as_of_date","value":"20260417"},{"label":"accession_number","value":"0001306763-26-000001"},{"label":"issuer_CIK","value":"0001812286"}],"primary_claim":"A Form 4 was filed on 2026-04-17 by Harrison Street Infrastructure Income Fund for the reporting period 2026-04-16, with Richard J. McCready as the reporting owner.","relevance_score":0.45,"sentiment":"neutral","source_quality":"medium","summary":"Harrison Street Infrastructure Income Fund (issuer) filed a Form 4 on 2026-04-17 covering a reporting period of 2026-04-16. The filing is by Richard J. McCready (via power of attorney).","topics":["SEC filing","Form 4","insider transaction disclosure (details not provided)"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 Harrison Street Infrastructure Income Fund \u00b7 Filed 20260417","ticker":"VCRDX","tickers":["VCRDX"],"title":"VCRDX filed 4","url":"https://www.sec.gov/Archives/edgar/data/1812286/0001306763-26-000001.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_66dca01bc {"_evidence_event_ids":["evt_66dca01bcd7e"]}...
|
signal_enriched:discovery_sec_filing_delta:279ed43 signal_enriched:discovery_sec_filing_delta:279ed43b1e3859c9...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_bd423cb8f136
|
evt_c440c02536a9
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/917851/0001292814-26-002379.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/917851/0001292814-26-002379.txt","company":"Vale S.A.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/917851/0001292814-26-002379.txt","article_chars":3781,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_00ca5f7d7df918c1","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/917851/0001292814-26-002379.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:22:43.635914+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/917851/0001292814-26-002379.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/917851/0001292814-26-002379.txt","source_event_id":"evt_cbb2be98d99e","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"6-K","fp":"ca2390a7cebade60","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-16","2026-04-17","2026-04-18","2026-04 (month covered)","2024-12-30","2025-08-28"],"entities":[{"asset_class":"equity","name":"Vale S.A.","relevance":"high","symbol":"VALE","type":"issuer"},{"asset_class":"other","name":"Board of Directors of Vale S.A.","relevance":"high","symbol":"","type":"governance_body"},{"asset_class":"other","name":"Executive Committee (Vale)","relevance":"high","symbol":"","type":"governance_body"},{"asset_class":"other","name":"Brazilian Ministry of Transport (MT)","relevance":"medium","symbol":"","type":"government_agency"},{"asset_class":"other","name":"National Land Transportation Agency (ANTT)","relevance":"medium","symbol":"","type":"government_agency"},{"asset_class":"other","name":"Infra S.A.","relevance":"medium","symbol":"","type":"entity"},{"asset_class":"other","name":"Office of the Attorney General of the Union (AGU)","relevance":"medium","symbol":"","type":"government_agency"},{"asset_class":"other","name":"Federal Court of Accounts (TCU)","relevance":"medium","symbol":"","type":"judicial_body"}],"event_type":"regulation","information_gaps":["What specifically changed versus the prior known state is not detailed in the provided text beyond stating that negotiations are being continued (no new terms, amendments, or quantified impacts are disclosed here).","No financial figures, cost estimates, or investment amounts are provided in the excerpt.","The excerpt does not specify the current status of negotiations or any timeline for TCU approval beyond stating it is expected to occur when approved by the TCU."],"key_facts":["Vale filed a Form 6-K for the month of April 2026.","Vale states that on April 16, 2026 its Board approved the continuation, by Vale\u2019s Executive Committee, of negotiations to optimize the Caraj\u00e1s Railway (EFC) and Vit\u00f3ria a Minas Railway (EFVM) Concession Contracts.","Vale says negotiations are being held with MT, ANTT, Infra S.A., and AGU within their respective legal authorities.","Vale reaffirms commitment to guidelines and general framework for the optimization process set forth in an agreement entered into on December 30, 2024, including the asset base and infrastructure works.","Vale states it is in full compliance with, and will continue to fully perform, all obligations under the Concession Contracts.","Vale expects that conclusion of the Concession Contracts optimization, when approved by the TCU, will provide greater predictability, legal certainty, and finality regarding obligations and investments, and support long-term operational efficiency and sustainability of its integrated logistics system.","The filing references prior disclosures on August 28, 2025 and December 30, 2024 regarding this matter."],"numeric_claims":[{"label":"Agreement date","value":"2024-12-30"},{"label":"Board approval date","value":"2026-04-16"},{"label":"Prior disclosure date (1)","value":"2025-08-28"}],"primary_claim":"Vale\u2019s Board approved the continuation of negotiations to optimize the Caraj\u00e1s Railway (EFC) and Vit\u00f3ria a Minas Railway (EFVM) concession contracts, with discussions ongoing with Brazilian government and related entities.","relevance_score":0.62,"sentiment":"neutral","source_quality":"high","summary":"Vale S.A. filed a Form 6-K in April 2026 announcing that its Board approved the continuation of negotiations to optimize its Caraj\u00e1s Railway and Vit\u00f3ria a Minas Railway concession contracts. The company states it remains fully compliant with concession obligations and expects TCU approval to provide greater predictability and legal certainty.","topics":["railway concession contracts","negotiations","Brazil transportation authorities","legal certainty","TCU approval","infrastructure works","logistics system sustainability"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 6-K \u00b7 Vale S.A. \u00b7 Filed 20260417","ticker":"VALE","tickers":["VALE"],"title":"VALE filed 6-K","url":"https://www.sec.gov/Archives/edgar/data/917851/0001292814-26-002379.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_cbb2be98d {"_evidence_event_ids":["evt_cbb2be98d99e"]}...
|
signal_enriched:discovery_sec_filing_delta:a722899 signal_enriched:discovery_sec_filing_delta:a722899cf3ee1f7d...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_ae33215fb963
|
evt_4fdd0a6b6c09
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1385849/0001062993-26-002047.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1385849/0001062993-26-002047.txt","company":"ENERGY FUELS INC","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1385849/0001062993-26-002047.txt","article_chars":2215,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_0f277ff39bff0ad9","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1385849/0001062993-26-002047.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:22:56.434463+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"Energy Fuels Inc.: Form 8-K - Filed by newsfilecorp.com","final_url":"https://www.sec.gov/Archives/edgar/data/1385849/0001062993-26-002047.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1385849/0001062993-26-002047.txt","source_event_id":"evt_492162688e9c","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"8-K","fp":"72385b8988039028","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.86,"dates_mentioned":["April 17, 2026","April 13, 2026","June 24, 2026"],"entities":[{"asset_class":"equity","name":"Energy Fuels Inc.","relevance":"high","symbol":"","type":"issuer"},{"asset_class":"person","name":"J. Birks Bovaird","relevance":"high","symbol":"","type":"director"},{"asset_class":"person","name":"Alexander G. Morrison","relevance":"high","symbol":"","type":"director"},{"asset_class":"other","name":"Board of Directors","relevance":"medium","symbol":"","type":"governance_body"}],"event_type":"other","information_gaps":["No prior known state is provided in the prompt, so the specific 'what changed vs prior known state' cannot be determined beyond the fact that this 8-K was filed.","The filing text excerpt does not include the registrant\u2019s address, telephone number, or any other Item sections beyond Item 5.02.","No information is provided about whether replacements/election of new directors will occur or who they might be."],"key_facts":["Form type: 8-K (Current Report).","Date of earliest event reported: April 17, 2026.","Item disclosed: Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers).","On April 13, 2026, Mr. J. Birks Bovaird notified the Board he would not seek re-election to the Board at the upcoming Annual Meeting of Shareholders.","On April 13, 2026, Mr. Alexander G. Morrison notified the Board he would not seek re-election to the Board at the upcoming Annual Meeting of Shareholders.","The decision of both directors not to seek re-election was not due to any disagreement with the Company on matters related to the Company\u2019s operations, policies, or practices.","The Annual Meeting of Shareholders is scheduled for June 24, 2026."],"numeric_claims":[{"label":"Annual Meeting date","value":"June 24, 2026"},{"label":"Director notification date","value":"April 13, 2026"},{"label":"Date of earliest event reported","value":"April 17, 2026"}],"primary_claim":"On April 13, 2026, directors J. Birks Bovaird and Alexander G. Morrison notified Energy Fuels Inc. they will not seek re-election to the Board at the June 24, 2026 Annual Meeting, and the decision was not due to any disagreement with the Company.","relevance_score":0.55,"sentiment":"neutral","source_quality":"high","summary":"Energy Fuels Inc. filed a Form 8-K on April 17, 2026 disclosing that two directors, J. Birks Bovaird and Alexander G. Morrison, notified the Board they will not seek re-election at the June 24, 2026 Annual Meeting of Shareholders.","topics":["SEC filing","Form 8-K","director departure","annual meeting","corporate governance"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 8-K \u00b7 ENERGY FUELS INC \u00b7 Filed 20260417","ticker":"UUUU","tickers":["UUUU"],"title":"UUUU filed 8-K","url":"https://www.sec.gov/Archives/edgar/data/1385849/0001062993-26-002047.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_492162688 {"_evidence_event_ids":["evt_492162688e9c"]}...
|
signal_enriched:discovery_sec_filing_delta:83b5546 signal_enriched:discovery_sec_filing_delta:83b5546636b2bdcc...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_30fc1ec05ede
|
evt_a4725188bfb6
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1385849/0001062993-26-002046.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1385849/0001062993-26-002046.txt","company":"ENERGY FUELS INC","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1385849/0001062993-26-002046.txt","article_chars":4999,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_11798db0c6f9ec5c","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1385849/0001062993-26-002046.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:23:01.652974+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"Energy Fuels Inc.: Form DEF 14A - Filed by newsfilecorp.com","final_url":"https://www.sec.gov/Archives/edgar/data/1385849/0001062993-26-002046.txt","html_truncated":true,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1385849/0001062993-26-002046.txt","source_event_id":"evt_7c081f165d21","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"DEF 14A","fp":"a1d3fddcf61802b0","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-17","2026-06-24","2026-04-15","2025-08"],"entities":[{"asset_class":"equity","name":"Energy Fuels Inc.","relevance":"high","symbol":"UUUU","type":"issuer"},{"asset_class":"person","name":"Ross Bhappu","relevance":"high","symbol":"","type":"individual"},{"asset_class":"person","name":"Mark Chalmers","relevance":"high","symbol":"","type":"individual"},{"asset_class":"organization","name":"Board of Directors of Energy Fuels","relevance":"medium","symbol":"","type":"governance_body"}],"event_type":"listing","information_gaps":["What changed vs prior known state is not provided in the signal (no prior filing/version details included).","No specific agenda items, director nominees, compensation matters, or voting proposals are included in the provided excerpt.","The SEC filing amendment number is shown as 'AMENDMENT NO. ___' but the actual amendment number is not provided in the text excerpt.","The provided text does not include the full list of 'items of business' referenced in the notice."],"key_facts":["The document is a Schedule Proxy Statement pursuant to Section 14(a) of the Securities Exchange Act of 1934 (definitive proxy statement).","Energy Fuels Inc. is the registrant/issuer.","The proxy statement is dated/indicated as filed April 17, 2026 in the provided text.","The annual meeting of shareholders is scheduled for Wednesday, June 24, 2026.","The meeting will be held via a live audio webcast with integrated slides and real-time balloting.","The proxy statement states Ross Bhappu was appointed President and Chief Executive Officer concurrently with former CEO Mark Chalmers\u2019 retirement on April 15, 2026.","The proxy statement states Ross Bhappu has served as the Company\u2019s President since August 2025."],"numeric_claims":[{"label":"Annual meeting date","value":"2026-06-24"},{"label":"Mark Chalmers retirement date","value":"2026-04-15"},{"label":"Ross Bhappu President since","value":"2025-08"},{"label":"Proxy statement filing date (as stated)","value":"2026-04-17"}],"primary_claim":"Energy Fuels Inc. filed a definitive proxy statement on Form DEF 14A for its annual meeting of shareholders to be held June 24, 2026.","relevance_score":0.62,"sentiment":"neutral","source_quality":"high","summary":"Energy Fuels Inc. filed a definitive proxy statement (DEF 14A) for its 2026 annual meeting of shareholders. The filing includes notice of the meeting and states that Ross Bhappu was appointed President and CEO concurrently with Mark Chalmers\u2019 retirement on April 15, 2026.","topics":["SEC proxy statement","DEF 14A","annual meeting of shareholders","corporate governance","CEO transition","virtual meeting"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form DEF 14A \u00b7 ENERGY FUELS INC \u00b7 Filed 20260417","ticker":"UUUU","tickers":["UUUU"],"title":"UUUU filed DEF 14A","url":"https://www.sec.gov/Archives/edgar/data/1385849/0001062993-26-002046.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_7c081f165 {"_evidence_event_ids":["evt_7c081f165d21"]}...
|
signal_enriched:discovery_sec_filing_delta:9d55ca7 signal_enriched:discovery_sec_filing_delta:9d55ca76ed49570d...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_6d2a13afb0ad
|
evt_c3f0e5026364
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001950047-26-003588.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001950047-26-003588.txt","company":"UNITED THERAPEUTICS Corp","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001950047-26-003588.txt","article_chars":1521,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_4c9e3208203e3c88","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001950047-26-003588.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:23:06.601812+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001950047-26-003588.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001950047-26-003588.txt","source_event_id":"evt_74e286640df1","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"144","fp":"7a00a6b997eff694","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.72,"dates_mentioned":["2026-04-17","2025-12-18","1999-03-24"],"entities":[{"asset_class":"equity","name":"UNITED THERAPEUTICS Corp","relevance":"high","symbol":"","type":"issuer"},{"asset_class":"equity","name":"Christopher Patusky","relevance":"high","symbol":"","type":"reporting_owner"},{"asset_class":"equity","name":"Morgan Stanley Smith Barney LLC","relevance":"medium","symbol":"","type":"broker"}],"event_type":"listing","information_gaps":["The text does not explicitly state the number of shares to be sold/disposed, the exact security class beyond \u201cCommon,\u201d or whether the transaction is a sale vs other disposition beyond the presence of \u201cStock Option Exercise.\u201d","No prior known state is provided in the prompt, so the \u201cwhat changed vs prior known state\u201d cannot be determined from the supplied text alone.","The filing\u2019s detailed table fields (e.g., share count, aggregate sale price, remaining shares) are not fully interpretable from the cleaned excerpt provided."],"key_facts":["SEC accession number: 0001950047-26-003588.","Conformed submission type: Form 144.","Filed as of date and date as of change: 2026-04-17.","Subject company: UNITED THERAPEUTICS Corp (CIK 0001082554).","Reporting-owner name: Christopher Patusky (CIK 0001231427).","Business address for issuer: 1000 Spring St, Silver Spring, MD 20910.","Filing values include: form type 144; SEC Act: 1933 Act; SEC file number: 000-26301.","Transaction-related fields shown include: \u201cStock Option Exercise\u201d and \u201cCash Y\u201d.","A numeric value shown: 578880.00.","Another numeric value shown: 43827686.","Dates shown include: 04/17/2026 and 12/18/2025.","Signature line shows: /s/ Christopher Patusky."],"numeric_claims":[{"label":"numeric_value_1","value":"578880.00"},{"label":"numeric_value_2","value":"43827686"}],"primary_claim":"On 2026-04-17, UNITED THERAPEUTICS Corp filed SEC Form 144 (accession 0001950047-26-003588).","relevance_score":0.35,"sentiment":"neutral","source_quality":"medium","summary":"United Therapeutics Corp filed a Form 144 on 2026-04-17. The filing indicates a director (Christopher Patusky) and includes details consistent with a common stock transaction tied to an option exercise.","topics":["SEC Form 144","insider/director sale/disposition","common stock","option exercise","United Therapeutics"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 144 \u00b7 UNITED THERAPEUTICS Corp \u00b7 Filed 20260417","ticker":"UTHR","tickers":["UTHR"],"title":"UTHR filed 144","url":"https://www.sec.gov/Archives/edgar/data/1082554/0001950047-26-003588.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_74e286640 {"_evidence_event_ids":["evt_74e286640df1"]}...
|
signal_enriched:discovery_sec_filing_delta:110b379 signal_enriched:discovery_sec_filing_delta:110b3793c81a84a4...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_155d10e6f8b4
|
evt_2375c9801d44
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1692376/0001950047-26-003613.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1692376/0001950047-26-003613.txt","company":"Velocity Financial, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1692376/0001950047-26-003613.txt","article_chars":2018,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_33295d70734659a9","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1692376/0001950047-26-003613.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:23:41.852955+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1692376/0001950047-26-003613.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1692376/0001950047-26-003613.txt","source_event_id":"evt_a3ed39547b1e","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"144","fp":"1fd54f594a325c9f","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.72,"dates_mentioned":["2026-04-17","2016-12-14","2025-01-13","2025-01-21","2025-01-21","2025-02-02","2025-03-18","2026-01-26","2026-02-02","2026-04-17","2025-04-17","2002-08-29"],"entities":[{"asset_class":"equity","name":"Velocity Financial, Inc.","relevance":"high","symbol":"VEL","type":"issuer"},{"asset_class":"equity","name":"Taylor Jeffrey T.","relevance":"medium","symbol":"","type":"reporting-owner_person"},{"asset_class":"equity","name":"Taylor Family Trust U/A DTD 08/29/2002","relevance":"high","symbol":"","type":"reporting-owner_trust"},{"asset_class":"equity","name":"Morgan Stanley Smith Barney LLC","relevance":"low","symbol":"","type":"broker"}],"event_type":"listing","information_gaps":["The provided text does not clearly state the total number of shares to be sold across the entire Form 144 in a single explicit field; numeric entries appear on multiple lines without fully unambiguous labels in the excerpt.","The excerpt does not explicitly state whether the transactions are completed or merely planned under Form 144 (beyond the presence of 10b5-1 references).","No explicit statement of aggregate proceeds, remaining shares, or sale window start/end dates is clearly extractable from the provided text beyond the dates shown on lines."],"key_facts":["SEC accession number: 0001950047-26-003613.","Conformed submission type: Form 144.","Filed as of date: 2026-04-17; date as of change: 2026-04-17.","Subject company: Velocity Financial, Inc. (CIK 0001692376; SEC file number 001-39183).","Former company name shown: Velocity Financial, LLC; date of name change: 2016-12-14.","Reporting owner includes Taylor Jeffrey T. (CIK 0001524986) and Taylor Family Trust U/A DTD 08/29/2002.","The document lists multiple common stock transactions tied to restricted stock awards and performance stock units, and references 10b5-1 sales for the trust.","Examples of numeric entries shown in the filing text include: 135,664.32 and 39,235,281; 36024.76 and 1772; 35400.00 and 1770 (exact mapping to each line item is not fully explicit in the provided text).","Signature shown: /s/ Jeffrey Taylor; date shown: 04/17/2026."],"numeric_claims":[{"label":"Form 144 filed date","value":"2026-04-17"},{"label":"Accession number","value":"0001950047-26-003613"},{"label":"Example value shown","value":"135664.32"},{"label":"Example share/quantity shown","value":"39235281"},{"label":"Example value shown","value":"36024.76"},{"label":"Example quantity shown","value":"1772"},{"label":"Example value shown","value":"35400.00"},{"label":"Example quantity shown","value":"1770"}],"primary_claim":"A Form 144 was filed by Velocity Financial, Inc. on 2026-04-17 (accession 0001950047-26-003613).","relevance_score":0.55,"sentiment":"neutral","source_quality":"medium","summary":"Velocity Financial, Inc. (VEL) filed a Form 144 on 2026-04-17. The filing relates to reported sales of restricted securities by Taylor Family Trust and includes specific share/price figures for multiple transactions.","topics":["SEC Form 144","restricted stock","performance stock units","10b5-1 sales","insider/trust sales disclosure"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 144 \u00b7 Velocity Financial, Inc. \u00b7 Filed 20260417","ticker":"VEL","tickers":["VEL"],"title":"VEL filed 144","url":"https://www.sec.gov/Archives/edgar/data/1692376/0001950047-26-003613.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_a3ed39547 {"_evidence_event_ids":["evt_a3ed39547b1e"]}...
|
signal_enriched:discovery_sec_filing_delta:ad66ae4 signal_enriched:discovery_sec_filing_delta:ad66ae49a1a81bed...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_649e7522c174
|
evt_e4ea7b18bd51
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001231427-26-000001.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001231427-26-000001.txt","company":"UNITED THERAPEUTICS Corp","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001231427-26-000001.txt","article_chars":1783,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_248f6ddd7c7a86f2","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001231427-26-000001.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:24:15.353837+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001231427-26-000001.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001231427-26-000001.txt","source_event_id":"evt_8dcca8929c7c","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"5d337d37e1526d1d","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.72,"dates_mentioned":["2026-04-17","2026-04-18T03:05:05.644967+00:00","2025-12-18","2017-06-21","2026-06-21","1999-03-24"],"entities":[{"asset_class":"equity","name":"UNITED THERAPEUTICS Corp","relevance":"high","symbol":"UTHR","type":"issuer"},{"asset_class":"person","name":"Christopher Patusky","relevance":"high","symbol":"","type":"reporting_person"},{"asset_class":"person","name":"John S. Hess, Jr.","relevance":"medium","symbol":"","type":"signatory"}],"event_type":"listing","information_gaps":["The cleaned text does not clearly label each Form 4 table row (e.g., whether each numeric line is shares acquired vs sold, and the exact share counts for each transaction) beyond the presence of Common Stock lines and the Rule 10b5-1 statement.","The signal indicates \"Filed 20260417\" but the provided structured context lists a filing_date of 2026-04-18T03:05:05.644967+00:00; the discrepancy is not explained in the text.","No explicit total shares bought/sold or total consideration amounts are clearly summarized in the provided excerpt beyond the individual numeric fields shown."],"key_facts":["SEC accession number: 0001231427-26-000001.","Form type: 4; filed as of date: 2026-04-17; conform ed period of report: 20260417.","Reporting owner: Christopher Patusky.","Issuer: United Therapeutics Corp (UTHR).","The filing includes Common Stock transactions dated 2026-04-17.","The filing text states: \"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on December 18, 2025.\"","The filing includes a signature: \"/s/ John S. Hess, Jr. under Power of Attorney\" dated 2026-04-17."],"numeric_claims":[{"label":"Option exercise price (per share)","value":"101.80"},{"label":"Sale price (per share)","value":"101.80"},{"label":"Number of shares (exercise/sale line item shown)","value":"2490.00"},{"label":"Option exercise price (per share)","value":"578.88"},{"label":"Number of shares (exercise/sale line item shown)","value":"1490.00"},{"label":"Option exercise price (per share)","value":"2910.00"},{"label":"Option exercise date shown","value":"2017-06-21"},{"label":"Option expiration date shown","value":"2026-06-21"}],"primary_claim":"On 2026-04-17, United Therapeutics filed Form 4 reporting that Christopher Patusky exercised stock options and sold shares pursuant to a Rule 10b5-1 trading plan dated December 18, 2025.","relevance_score":0.45,"sentiment":"neutral","source_quality":"medium","summary":"United Therapeutics (UTHR) filed a Form 4 on 2026-04-17 reporting transactions by reporting person Christopher Patusky. The filing states the activity relates to the exercise of stock options and subsequent sale of shares under a Rule 10b5-1 trading plan entered on 2025-12-18.","topics":["SEC Form 4","insider transaction","stock option exercise","Rule 10b5-1 trading plan","common stock sale"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 UNITED THERAPEUTICS Corp \u00b7 Filed 20260417","ticker":"UTHR","tickers":["UTHR"],"title":"UTHR filed 4","url":"https://www.sec.gov/Archives/edgar/data/1082554/0001231427-26-000001.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_8dcca8929 {"_evidence_event_ids":["evt_8dcca8929c7c"]}...
|
signal_enriched:discovery_sec_filing_delta:8e25661 signal_enriched:discovery_sec_filing_delta:8e25661af395f767...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_fbde7b205300
|
evt_115c0375aef1
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1947244/0001493152-26-017119.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1947244/0001493152-26-017119.txt","company":"U.S. GoldMining Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1947244/0001493152-26-017119.txt","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_e4ad08fce21f80dc","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1947244/0001493152-26-017119.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:24:20.947883+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1947244/0001493152-26-017119.txt","html_truncated":true,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1947244/0001493152-26-017119.txt","source_event_id":"evt_10a9d3059db4","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"POS AM","fp":"9a0bcb5d6ab6d55c","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-16","2026-04-17","2026-04-18","2023-02-10","2023-04-19"],"entities":[{"asset_class":"equity","name":"U.S. GoldMining Inc.","relevance":"high","symbol":"","type":"issuer"},{"asset_class":"regulation","name":"U.S. Securities and Exchange Commission (SEC)","relevance":"high","symbol":"","type":"regulator"},{"asset_class":"executive","name":"Tim Smith","relevance":"medium","symbol":"","type":"person"}],"event_type":"listing","information_gaps":["The provided text is truncated mid-sentence (\u201cone sh\u201d), so the full description of the warrant terms is not fully captured.","The signal context includes \u201cFiled 20260417\u201d and the structured context includes a filing timestamp of 2026-04-18T03:05:05.644967+00:00; the relationship between these timestamps is not explained in the provided text.","No explicit \u201cwhat changed vs prior known state\u201d details beyond the stated conversion from Form S-1 to Form S-3 and incorporation of periodic reports by reference are included in the excerpt.","No financial guidance or updated financial figures are included in the provided text excerpt."],"key_facts":["The document is titled \u201cPost-Effective Amendment No. 1 to FORM S-1 ON FORM S-3\u201d for U.S. GoldMining Inc.","It references Registration No. 333-269693.","The registrant states it filed the original Form S-1 on February 10, 2023 and that the SEC declared it effective on April 19, 2023.","The registrant states this Post-Effective Amendment is being filed to convert the registration statement from Form S-1 to Form S-3 and to update the registration statement, including incorporating periodic reports by reference.","The registrant states that, pursuant to Rule 429, the prospectus in the registration statement has been combined into the prospectus contained in this Post-Effective Amendment.","The registrant states the original registration statement registered the offer and sale of 2,000,000 units, with each unit consisting of one share of common stock and one warrant to purchase one share (the text cuts off mid-sentence after \u201cone sh\u201d)."],"numeric_claims":[{"label":"Registration No.","value":"333-269693"},{"label":"Original S-1 filing date","value":"2023-02-10"},{"label":"Original S-1 effectiveness date","value":"2023-04-19"},{"label":"Post-Effective Amendment number","value":"1"},{"label":"Units registered in original registration statement","value":"2,000,000"}],"primary_claim":"U.S. GoldMining Inc. filed Post-Effective Amendment No. 1 to its Form S-1 registration statement on Form S-3 (Registration No. 333-269693).","relevance_score":0.62,"sentiment":"neutral","source_quality":"high","summary":"U.S. GoldMining Inc. filed Post-Effective Amendment No. 1 to its Form S-1 registration statement on Form S-3. The filing converts the S-1 into an S-3 and updates the registration statement by incorporating periodic reports by reference.","topics":["SEC filing","registration statement","Form S-3","post-effective amendment","Form S-1 conversion","periodic reports by reference","prospectus update"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form POS AM \u00b7 U.S. GoldMining Inc. \u00b7 Filed 20260417","ticker":"USGOW","tickers":["USGOW"],"title":"USGOW filed POS AM","url":"https://www.sec.gov/Archives/edgar/data/1947244/0001493152-26-017119.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_10a9d3059 {"_evidence_event_ids":["evt_10a9d3059db4"]}...
|
signal_enriched:discovery_sec_filing_delta:32aa069 signal_enriched:discovery_sec_filing_delta:32aa0692eed509ef...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_eb7054f6243e
|
evt_9b5fda69bd81
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/920427/0001950047-26-003592.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/920427/0001950047-26-003592.txt","company":"UNITY BANCORP INC /NJ/","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/920427/0001950047-26-003592.txt","article_chars":1774,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_10b1859998d14bcb","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/920427/0001950047-26-003592.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:24:26.375436+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/920427/0001950047-26-003592.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/920427/0001950047-26-003592.txt","source_event_id":"evt_bfafb840d909","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"144","fp":"0ae9cb7ca5333fc2","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.62,"dates_mentioned":["2026-04-17","2026-01-02","2026-01-03","2026-01-27","1994-03-16","2026-01-03","2026-01-02","2026-01-27","2026-01-03"],"entities":[{"asset_class":"equity","name":"UNITY BANCORP INC /NJ/","relevance":"high","symbol":"UNTY","type":"issuer"},{"asset_class":"equity","name":"Mary E. Gross","relevance":"high","symbol":"","type":"reporting_owner"},{"asset_class":"equity","name":"UNITY BANK","relevance":"medium","symbol":"","type":"company_affiliate"},{"asset_class":"equity","name":"Morgan Stanley Smith Barney LLC","relevance":"medium","symbol":"","type":"broker"}],"event_type":"listing","information_gaps":["The cleaned text does not clearly specify the exact number of shares sold vs. remaining, nor the sale price per share; it only shows partial numeric fields (e.g., 116220.96, 10016427, and quantities like 625/550/400/500) without explicit labels.","The filing\u2019s full Form 144 table fields (e.g., aggregate amount, number of shares, sale method) are not fully interpretable from the provided cleaned excerpt.","What changed vs prior known state is not provided in the prompt (no prior Form 144 or earlier state to compare)."],"key_facts":["SEC accession number: 0001950047-26-003592.","Form type: 144.","Filed as of date: 2026-04-17 (date as of change: 2026-04-17).","Subject company: UNITY BANCORP INC /NJ/ (CIK: 0000920427).","Reporting owner: Mary E. Gross (Director).","Issuer exchange/market shown: NASDAQ (in the filing values).","The filing includes multiple transaction lines for \u201cRestricted Stock Issuer N\u201d with dates in January 2026 (01/02/2026, 01/03/2026, 01/27/2026) and a final signature date of 04/17/2026.","One transaction line shows a quantity/value figure: 116220.96 and another shows 10016427 (as presented in the cleaned text)."],"numeric_claims":[{"label":"transaction_value_or_amount_shown","value":"116220.96"},{"label":"shares_or_quantity_shown","value":"10016427"},{"label":"transaction_quantity_shown","value":"625"},{"label":"transaction_quantity_shown","value":"550"},{"label":"transaction_quantity_shown","value":"400"},{"label":"transaction_quantity_shown","value":"500"}],"primary_claim":"On 2026-04-17, UNITY BANCORP INC /NJ/ filed SEC Form 144 (accession 0001950047-26-003592) reporting Mary Gross\u2019s restricted common stock transactions.","relevance_score":0.45,"sentiment":"neutral","source_quality":"medium","summary":"UNITY BANCORP INC /NJ/ filed a Form 144 on 2026-04-17. The filing lists Mary Gross (Director) as the reporting owner and indicates sales of restricted common stock with multiple transaction entries dated in January 2026.","topics":["SEC Form 144","restricted stock","insider/director sale","reporting owner","NASDAQ common stock"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 144 \u00b7 UNITY BANCORP INC /NJ/ \u00b7 Filed 20260417","ticker":"UNTY","tickers":["UNTY"],"title":"UNTY filed 144","url":"https://www.sec.gov/Archives/edgar/data/920427/0001950047-26-003592.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_bfafb840d {"_evidence_event_ids":["evt_bfafb840d909"]}...
|
signal_enriched:discovery_sec_filing_delta:830d197 signal_enriched:discovery_sec_filing_delta:830d197319253c50...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_653c150e8034
|
evt_84ab2a5b341e
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/752642/0001493152-26-017174.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/752642/0001493152-26-017174.txt","company":"UMH PROPERTIES, INC.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/752642/0001493152-26-017174.txt","article_chars":360,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_3816f99e90901e76","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/752642/0001493152-26-017174.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:24:36.694258+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/752642/0001493152-26-017174.txt","html_truncated":true,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/752642/0001493152-26-017174.txt","source_event_id":"evt_77c24a6ba549","source_quality":"low","status_code":200,"version":"signal_enrichment_v2"},"form_type":"DEFA14A","fp":"55a21d5a682b9ae7","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.6,"dates_mentioned":["2026-04-17"],"entities":[{"asset_class":"equity","name":"UMH Properties, Inc.","relevance":"high","symbol":"","type":"issuer"}],"event_type":"other","information_gaps":["No proxy solicitation details, agenda items, or disclosed proposals are present in the provided cleaned text.","No indication of what changed versus a prior known state is included in the provided text (no prior filing comparison content).","The filing timestamp in the deterministic context (2026-04-18T03:05:05.644967+00:00) is not corroborated by the provided article text.","No filing fee amount or checked boxes details are provided beyond the generic 'Payment of Filing Fee' section header/instructions."],"key_facts":["Form type: DEFA14A.","Document title/section: Schedule 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934.","Issuer/registrant name shown: UMH Properties, Inc.","Filing date shown in source summary: 2026-04-17."],"numeric_claims":[],"primary_claim":"UMH Properties, Inc. filed Form DEFA14A (Schedule 14A proxy statement) on 2026-04-17.","relevance_score":0.35,"sentiment":"neutral","source_quality":"low","summary":"UMH Properties, Inc. filed a Schedule 14A proxy statement on Form DEFA14A. The provided text includes only the filing header/instructions and does not disclose substantive proxy content.","topics":["SEC filing","proxy statement","Schedule 14A","DEFA14A"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form DEFA14A \u00b7 UMH PROPERTIES, INC. \u00b7 Filed 20260417","ticker":"UMH","tickers":["UMH"],"title":"UMH filed DEFA14A","url":"https://www.sec.gov/Archives/edgar/data/752642/0001493152-26-017174.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_77c24a6ba {"_evidence_event_ids":["evt_77c24a6ba549"]}...
|
signal_enriched:discovery_sec_filing_delta:da6bfba signal_enriched:discovery_sec_filing_delta:da6bfbacd1d4a702...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_1661d24c42c5
|
evt_554b967137e6
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/752642/0001493152-26-017167.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/752642/0001493152-26-017167.txt","company":"UMH PROPERTIES, INC.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/752642/0001493152-26-017167.txt","article_chars":4999,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_fbdffcfa179c5c60","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/752642/0001493152-26-017167.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:25:32.863119+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/752642/0001493152-26-017167.txt","html_truncated":true,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/752642/0001493152-26-017167.txt","source_event_id":"evt_7cba05311371","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"DEF 14A","fp":"abae15683e34e4c8","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.86,"dates_mentioned":["2026-04-17","2026-05-27","2026-03-06","2026-12-31","2025-12-31"],"entities":[{"asset_class":"equity","name":"UMH Properties, Inc.","relevance":"high","symbol":"","type":"issuer"},{"asset_class":"professional_services","name":"PKF O\u2019Connor Davies, LLP","relevance":"medium","symbol":"","type":"auditor"},{"asset_class":"regulation","name":"U.S. Securities and Exchange Commission","relevance":"medium","symbol":"","type":"regulator"}],"event_type":"listing","information_gaps":["What changed versus prior known state is not provided in the signal text (no prior filing details or diff context included).","The filing\u2019s SEC filing timestamp is given in the deterministic context, but the article text itself does not explicitly state the filing date/time.","No financial guidance or quantitative financial implications are disclosed in the provided excerpt beyond the described shareholder proposals."],"key_facts":["Form DEF 14A proxy statement filed for UMH Properties, Inc.","Annual Meeting of Shareholders scheduled for Wednesday, May 27, 2026 at 4:00 p.m. Eastern Time.","Meeting location: offices of the Company at Juniper Business Plaza, 3499 Route 9 North, Suite 3-C, Freehold, New Jersey 07728.","Shareholders will vote on: (1) election of four Class II directors to hold office until the annual meeting of shareholders in 2029 and until successors are elected and qualified; (2) ratification of PKF O\u2019Connor Davies, LLP as independent registered public accounting firm for the year ending December 31, 2026; (3) advisory resolution to approve compensation of executive officers for the year ended December 31, 2025; (4) other business.","Record date for determining shareholders entitled to notice and vote: close of business on March 6, 2026.","Proxy materials were stated as being distributed on or about April 17, 2026.","The filing states no fee required for the proxy filing (Payment of Filing Fee: \u2612 No fee required)."],"numeric_claims":[{"label":"Annual meeting date","value":"2026-05-27"},{"label":"Annual meeting time (ET)","value":"4:00 p.m."},{"label":"Record date","value":"2026-03-06"},{"label":"Distribution date (proxy materials)","value":"on or about 2026-04-17"},{"label":"Number of directors to elect","value":"4"},{"label":"Class of directors","value":"Class II"},{"label":"Director term end (annual meeting year)","value":"2029"},{"label":"Independent auditor year ending","value":"2026-12-31"},{"label":"Executive compensation advisory vote year ended","value":"2025-12-31"}],"primary_claim":"UMH Properties, Inc. filed a DEF 14A proxy statement for its 2026 annual meeting of shareholders on May 27, 2026.","relevance_score":0.55,"sentiment":"neutral","source_quality":"high","summary":"UMH Properties, Inc. filed its 2026 proxy statement on Form DEF 14A for its annual meeting of shareholders scheduled for May 27, 2026. The filing includes proposals to elect four Class II directors, ratify the company\u2019s independent auditor for the year ending December 31, 2026, and approve executive compensation for the year ended December 31, 2025.","topics":["SEC filing","proxy statement","annual meeting","board of directors","independent auditor","executive compensation","shareholder voting"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form DEF 14A \u00b7 UMH PROPERTIES, INC. \u00b7 Filed 20260417","ticker":"UMH","tickers":["UMH"],"title":"UMH filed DEF 14A","url":"https://www.sec.gov/Archives/edgar/data/752642/0001493152-26-017167.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_7cba05311 {"_evidence_event_ids":["evt_7cba05311371"]}...
|
signal_enriched:discovery_sec_filing_delta:dbc92dd signal_enriched:discovery_sec_filing_delta:dbc92dd42b14b8ab...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_7affb6d69013
|
evt_09ac0061bd32
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1863127/0001193125-26-160347.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1863127/0001193125-26-160347.txt","company":"Tyra Biosciences, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1863127/0001193125-26-160347.txt","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_9960a026972b23eb","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1863127/0001193125-26-160347.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:25:43.577463+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"8-K","final_url":"https://www.sec.gov/Archives/edgar/data/1863127/0001193125-26-160347.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1863127/0001193125-26-160347.txt","source_event_id":"evt_6cf6b0b7f319","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"8-K","fp":"c57f560c2e06ef6d","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-16","2026-04-17","2026-04-18","April 2022","December 2016","November 2021","October 2015","December 2016","2013","2015","2010","2012","February 2026","November 2025","January 2024","September 2022","September 2018","January 2021","June 2022","July 2025","July 2023","April 2025","August 2022","March 2023"],"entities":[{"asset_class":"equity","name":"Tyra Biosciences, Inc.","relevance":"primary","symbol":"TYRA","type":"issuer"},{"asset_class":"person","name":"Habib J. Dable","relevance":"primary","symbol":"","type":"individual"},{"asset_class":"other","name":"Nominating and Corporate Governance Committee","relevance":"secondary","symbol":"","type":"committee"},{"asset_class":"other","name":"RA Capital Management, L.P.","relevance":"background","symbol":"","type":"organization"},{"asset_class":"other","name":"Acceleron Pharma Inc.","relevance":"background","symbol":"","type":"organization"},{"asset_class":"other","name":"Merck","relevance":"background","symbol":"","type":"organization"}],"event_type":"listing","information_gaps":["The filing\u2019s SEC \u201cItem\u201d section(s) are not explicitly captured in the provided text (the excerpt includes narrative but does not show the Item number labels).","The signal indicates a \u201cdelta\u201d vs prior known state, but no prior state content is provided here, so the exact change relative to prior disclosures cannot be verified beyond the contents of this 8-K.","The excerpt ends mid-sentence (\u201cThere are no arrangements or understandings\u2026 w\u201d), so any additional required disclosures after that point are not included in the provided text."],"key_facts":["Tyra Biosciences filed a Form 8-K with a date of report of April 16, 2026.","On April 16, 2026, the board approved an increase in the number of authorized directors from nine to ten.","On April 16, 2026, the board appointed Habib J. Dable as a Class II director.","Mr. Dable\u2019s initial term is stated to expire at the Company\u2019s 2026 annual meeting of stockholders.","In connection with the appointment, Mr. Dable was granted options to purchase 44,400 shares of the Company\u2019s common stock.","The options\u2019 exercise price is stated to equal the fair market value of the Company\u2019s common stock on the date of grant.","The options are stated to vest in substantially equal monthly installments over 36 months following the date of grant.","Mr. Dable will receive cash compensation for service on the board and committees under the Company\u2019s Non-Employee Director Compensation Program.","Mr. Dable entered into the Company\u2019s standard form of indemnification agreement (form filed with the Company\u2019s most recent annual report on Form 10-K)."],"numeric_claims":[{"label":"authorized directors increased from","value":"9 to 10"},{"label":"Class II director initial term expires","value":"2026 annual meeting of stockholders"},{"label":"options granted (shares)","value":"44,400"},{"label":"option vesting period","value":"36 months"},{"label":"monthly vesting installments","value":"substantially equal monthly installments over 36 months"},{"label":"director age (stated)","value":"56"}],"primary_claim":"On April 16, 2026, Tyra Biosciences\u2019 board approved an increase in authorized directors from nine to ten and appointed Habib J. Dable as a Class II director with an initial term expiring at the 2026 annual meeting of stockholders.","relevance_score":0.55,"sentiment":"neutral","source_quality":"high","summary":"Tyra Biosciences filed a Form 8-K reporting that its board increased authorized directors from nine to ten and appointed Habib J. Dable as a Class II director on April 16, 2026.","topics":["8-K","board of directors","director appointment","corporate governance","executive/board compensation","biopharmaceuticals"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 8-K \u00b7 Tyra Biosciences, Inc. \u00b7 Filed 20260417","ticker":"TYRA","tickers":["TYRA"],"title":"TYRA filed 8-K","url":"https://www.sec.gov/Archives/edgar/data/1863127/0001193125-26-160347.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_6cf6b0b7f {"_evidence_event_ids":["evt_6cf6b0b7f319"]}...
|
signal_enriched:discovery_sec_filing_delta:319d929 signal_enriched:discovery_sec_filing_delta:319d9291b2ad7543...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_c8de6663280f
|
evt_ef41a4827855
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1863127/0001193125-26-160360.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1863127/0001193125-26-160360.txt","company":"Tyra Biosciences, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1863127/0001193125-26-160360.txt","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_dce15c670c8cd38f","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1863127/0001193125-26-160360.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:25:49.410060+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"DEF 14A","final_url":"https://www.sec.gov/Archives/edgar/data/1863127/0001193125-26-160360.txt","html_truncated":true,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1863127/0001193125-26-160360.txt","source_event_id":"evt_03f79786a286","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"DEF 14A","fp":"bffc451cfdd4cb54","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-17","2026-05-28"],"entities":[{"asset_class":"equity","name":"Tyra Biosciences, Inc.","relevance":"high","symbol":"TYRA","type":"issuer_company"},{"asset_class":"regulator","name":"Securities and Exchange Commission (SEC)","relevance":"medium","symbol":"","type":"regulator"}],"event_type":"listing","information_gaps":["The specific agenda items/matters to be voted on are referenced as being 'more fully described in the attached proxy statement,' but the actual items are not included in the provided text.","No prior known state is provided in the prompt, so the 'what changed vs prior known state' cannot be determined from the supplied information.","No financial guidance or financial implications are disclosed in the provided excerpt."],"key_facts":["Tyra Biosciences, Inc. invites stockholders to its Annual Meeting of Stockholders.","The Annual Meeting is scheduled for Thursday, May 28, 2026 at 10:00 a.m. Pacific Time.","The Annual Meeting will be completely virtual and conducted via live webcast, with no physical meeting location.","Stockholders must register at www.proxydocs.com/TYRA to be admitted to the live webcast.","Registration requires a Control Number included in the Notice of Internet Availability of Proxy Materials, the proxy card, or accompanying instructions.","The company elected to furnish proxy materials by providing internet access rather than mailing printed copies, using SEC rules.","Most stockholders will receive a Notice of Internet Availability with instructions to access proxy materials and vote via the Internet.","Stockholders can vote online during the meeting even if they previously submitted a proxy."],"numeric_claims":[{"label":"Annual meeting date","value":"2026-05-28"},{"label":"Annual meeting time (Pacific Time)","value":"10:00 a.m."}],"primary_claim":"Tyra Biosciences, Inc. filed Form DEF 14A for its 2026 annual meeting of stockholders to be held virtually on May 28, 2026 at 10:00 a.m. Pacific Time.","relevance_score":0.55,"sentiment":"neutral","source_quality":"high","summary":"Tyra Biosciences, Inc. filed its DEF 14A proxy statement for its 2026 annual meeting of stockholders. The filing states the meeting will be completely virtual and held on May 28, 2026 via live webcast.","topics":["proxy statement","annual meeting of stockholders","virtual meeting","internet availability of proxy materials"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form DEF 14A \u00b7 Tyra Biosciences, Inc. \u00b7 Filed 20260417","ticker":"TYRA","tickers":["TYRA"],"title":"TYRA filed DEF 14A","url":"https://www.sec.gov/Archives/edgar/data/1863127/0001193125-26-160360.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_03f79786a {"_evidence_event_ids":["evt_03f79786a286"]}...
|
signal_enriched:discovery_sec_filing_delta:8ffa200 signal_enriched:discovery_sec_filing_delta:8ffa200090d4aeb8...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_90f16e5f9f56
|
evt_70bfcb9525d3
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1863127/0001193125-26-160364.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1863127/0001193125-26-160364.txt","company":"Tyra Biosciences, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1863127/0001193125-26-160364.txt","article_chars":3713,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_6bdfe54f0205036f","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1863127/0001193125-26-160364.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:25:55.906651+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"DEFA14A","final_url":"https://www.sec.gov/Archives/edgar/data/1863127/0001193125-26-160364.txt","html_truncated":true,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1863127/0001193125-26-160364.txt","source_event_id":"evt_aa6a9083d8e4","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"DEFA14A","fp":"f9f453f5c0124f8c","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-02","2026-05-18","2026-05-28","2026-12-31"],"entities":[{"asset_class":"equity","name":"Tyra Biosciences, Inc.","relevance":"high","symbol":"","type":"issuer"},{"asset_class":"other","name":"Ernst & Young LLP","relevance":"medium","symbol":"","type":"auditor"},{"asset_class":"other","name":"Habib J. Dable","relevance":"medium","symbol":"","type":"director_nominee"},{"asset_class":"other","name":"Susan Moran, M.D., M.S.C.E.","relevance":"medium","symbol":"","type":"director_nominee"},{"asset_class":"other","name":"Robert More","relevance":"medium","symbol":"","type":"director_nominee"},{"asset_class":"other","name":"SEC (U.S. Securities and Exchange Commission)","relevance":"medium","symbol":"","type":"regulator"}],"event_type":"listing","information_gaps":["What specifically changed versus the prior known state is not provided in the signal text (no prior filing comparison content included).","The filing\u2019s amendment number is shown as blank: \u201c(Amendment No. )\u201d.","The filing\u2019s \u201cFiled by the Registrant\u201d vs \u201cFiled by a Party other than the Registrant\u201d checkbox state is not explicitly confirmed in the provided text.","No financial guidance or financial implications are disclosed in the provided excerpt beyond auditor ratification and governance proposals."],"key_facts":["Form type: DEFA14A (Schedule 14A proxy statement).","Issuer: Tyra Biosciences, Inc.","Annual Meeting date/time: Thursday, May 28, 2026 at 10:00 AM Pacific Time.","Stockholders of record date: April 2, 2026.","Board recommends a vote FOR proposals 1 and 2.","Proposal 1: elect three directors as Class II directors for three-year terms expiring at the 2029 Annual Meeting (named nominees: Habib J. Dable; Susan Moran, M.D., M.S.C.E.; Robert More).","Proposal 2: ratify the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026.","Proposal 3: transact such other business as may properly come before the Annual Meeting."],"numeric_claims":[{"label":"Annual meeting date","value":"2026-05-28"},{"label":"Annual meeting time (PT)","value":"10:00 AM Pacific Time"},{"label":"Record date","value":"2026-04-02"},{"label":"Fiscal year end for auditor ratification","value":"2026-12-31"},{"label":"Control number request deadline for paper materials","value":"2026-05-18"}],"primary_claim":"Tyra Biosciences, Inc. filed Form DEFA14A (Schedule 14A proxy statement) for its annual meeting on May 28, 2026, with proposals to elect three directors and ratify Ernst & Young LLP.","relevance_score":0.62,"sentiment":"neutral","source_quality":"high","summary":"Tyra Biosciences, Inc. filed a Schedule 14A proxy statement (DEFA14A) with the SEC for its annual meeting of stockholders. The filing includes proposals to elect three Class II directors and to ratify Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026.","topics":["SEC filing","proxy statement","annual meeting of stockholders","director election","independent auditor ratification","corporate governance"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form DEFA14A \u00b7 Tyra Biosciences, Inc. \u00b7 Filed 20260417","ticker":"TYRA","tickers":["TYRA"],"title":"TYRA filed DEFA14A","url":"https://www.sec.gov/Archives/edgar/data/1863127/0001193125-26-160364.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_aa6a9083d {"_evidence_event_ids":["evt_aa6a9083d8e4"]}...
|
signal_enriched:discovery_sec_filing_delta:046d21c signal_enriched:discovery_sec_filing_delta:046d21c341aa04c9...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_7b36e08d3add
|
evt_fb14f457f3d8
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001959173-26-002971.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001959173-26-002971.txt","company":"Twist Bioscience Corp","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001959173-26-002971.txt","article_chars":2227,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_91dfa6f1e7cf0243","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001959173-26-002971.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:26:10.583427+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001959173-26-002971.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001959173-26-002971.txt","source_event_id":"evt_1c1914e351a7","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"144","fp":"5f063971bb1028d6","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-17","2026-04-14","2026-04-09","2026-02-23","2026-02-20","2026-02-12","2026-02-20","2025-08-20","2025-05-08","2025-10-01","2025-08-20"],"entities":[{"asset_class":"equity","name":"Twist Bioscience Corp","relevance":"high","symbol":"TWST","type":"issuer"},{"asset_class":"equity","name":"Adam Laponis","relevance":"high","symbol":"","type":"reporting_owner"},{"asset_class":"equity","name":"Fidelity Brokerage Services LLC","relevance":"medium","symbol":"","type":"broker_or_agent"}],"event_type":"listing","information_gaps":["The signal is labeled \u201cdiscovery_sec_filing_delta,\u201d but no prior known state or earlier filing is provided in the prompt, so the \u201cwhat changed vs prior\u201d cannot be determined from the supplied text.","The cleaned text shows multiple transaction lines, but not all fields are fully labeled in a way that allows unambiguous mapping of every column (e.g., whether each dollar figure is total sale value vs. price*shares) beyond the presence of the numbers as written.","No explicit total shares to be sold across all entries is provided in a single consolidated line in the supplied text."],"key_facts":["SEC accession number: 0001959173-26-002971.","Form type: 144.","Filed as of date: 2026-04-17 (DATE AS OF CHANGE: 2026-04-17).","Subject company: Twist Bioscience Corp (CIK: 0001581280; SEC file number: 001-38720).","Reporting owner: Adam Laponis (CIK: 0001827198).","Filing indicates transactions in common stock (NASDAQ listed per text: \u201cNASDAQ Common\u201d).","The filing includes entries referencing \u201cRestricted Stock Vesting\u201d and \u201cESPP Purchase\u201d with associated dates and share counts/dollar amounts (exact line items shown in the text).","Example transaction lines shown in the text include: 7000 shares for 2026-02-12 with $350,000.00; 2085 shares for 2026-02-23 with $97,389.93; 2597 shares for 2026-04-09 with $129,561.48; 3000 shares for 2026-04-14 with $165,000.00; and an earlier line dated 2025-08-20 referencing restricted stock vesting and an ESPP purchase (share counts/dollar amounts present in the text)."],"numeric_claims":[{"label":"Shares (example)","value":"7000"},{"label":"Dollar amount (example)","value":"350000.00"},{"label":"Shares (example)","value":"2085"},{"label":"Dollar amount (example)","value":"97389.93"},{"label":"Shares (example)","value":"2597"},{"label":"Dollar amount (example)","value":"129561.48"},{"label":"Shares (example)","value":"3000"},{"label":"Dollar amount (example)","value":"165000.00"}],"primary_claim":"On 2026-04-17, Twist Bioscience Corp filed SEC Form 144 (accession 0001959173-26-002971) disclosing common stock sale activity by Adam Laponis, including multiple transactions with share quantities and dollar amounts.","relevance_score":0.62,"sentiment":"neutral","source_quality":"high","summary":"Twist Bioscience Corp (TWST) filed a Form 144 on 2026-04-17 disclosing planned sales of common stock by reporting owner Adam Laponis. The filing lists multiple sale/transaction entries tied to restricted stock vesting and an ESPP purchase, with specified share counts and prices.","topics":["SEC Form 144","insider/affiliate sale disclosure","common stock","restricted stock vesting","ESPP purchase"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 144 \u00b7 Twist Bioscience Corp \u00b7 Filed 20260417","ticker":"TWST","tickers":["TWST"],"title":"TWST filed 144","url":"https://www.sec.gov/Archives/edgar/data/1581280/0001959173-26-002971.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_1c1914e35 {"_evidence_event_ids":["evt_1c1914e351a7"]}...
|
signal_enriched:discovery_sec_filing_delta:437d5ea signal_enriched:discovery_sec_filing_delta:437d5eaeeda099ca...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|
|
sig_dd682d6e5110
|
evt_89428648f207
|
NULL
|
discovery_sec_filing_delta
|
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1758730/0001758730-26-000090.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1758730/0001758730-26-000090.txt","company":"Tradeweb Markets Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1758730/0001758730-26-000090.txt","article_chars":2609,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_4c20f691c6044672","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1758730/0001758730-26-000090.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:26:16.254059+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1758730/0001758730-26-000090.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1758730/0001758730-26-000090.txt","source_event_id":"evt_5e3a9f20c18a","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"7c8b14d06a057e45","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-17","2026-04-15","2026-04-17T03:05:05.644967+00:00","2026-04-15","2025-11-03","2027-03-15","2027-03-17","2028-03-15","2028-03-17","2029-03-15"],"entities":[{"asset_class":"equity","name":"Tradeweb Markets Inc.","relevance":"high","symbol":"","type":"issuer"},{"asset_class":"equity","name":"Justin Peterson","relevance":"high","symbol":"","type":"reporting_person"},{"asset_class":"equity","name":"Douglas Friedman","relevance":"low","symbol":"","type":"attorney_in_fact"}],"event_type":"listing","information_gaps":["No prior known state is provided, so the specific 'delta' versus earlier disclosures cannot be determined from the supplied text.","The cleaned text does not explicitly state the total number of shares sold in the transaction (only RSU counts included in the amount are shown).","No explicit Form 4 table fields (e.g., shares sold count, transaction code) are included in the provided excerpt beyond the narrative footnote and some header values.","No issuer ticker/symbol is provided in the text, so a standardized symbol cannot be populated."],"key_facts":["SEC Form 4 filed as of 2026-04-17 for period of report 2026-04-15.","Reporting person: Justin Peterson, identified as Chief Technology Officer.","Transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 3, 2025.","The price reported in Column 4 is a weighted average price.","Shares were sold in multiple transactions at prices ranging from $119.57 to $122.42 (inclusive).","The filing includes an amount that includes (i) 2,548 unvested RSUs scheduled to vest on March 15, 2027, (ii) 4,485 unvested RSUs scheduled to vest in equal installments on March 17, 2027 and March 17, 2028, and (iii) 8,037 unvested RSUs scheduled to vest in equal installments on March 15, 2027, March 15, 2028 and March 15, 2029, subject to continued employment through the applicable vesting date."],"numeric_claims":[{"label":"weighted_average_price","value":"120.6586"},{"label":"price_range_min","value":"119.57"},{"label":"price_range_max","value":"122.42"},{"label":"RSUs_unvested_1","value":"2548"},{"label":"RSUs_unvested_2","value":"4485"},{"label":"RSUs_unvested_3","value":"8037"}],"primary_claim":"On 2026-04-17, Tradeweb Markets Inc. filed Form 4 reporting that Justin Peterson sold shares under a Rule 10b5-1 trading plan adopted on November 3, 2025, with sales at weighted-average price $120.6586 and prices ranging from $119.57 to $122.42.","relevance_score":0.62,"sentiment":"neutral","source_quality":"high","summary":"Tradeweb Markets Inc. reported a Form 4 filing on 2026-04-17 covering transactions by Justin Peterson (Chief Technology Officer). The filing indicates shares were sold under a Rule 10b5-1 trading plan and includes details on weighted-average price and RSU-related share amounts.","topics":["SEC Form 4","insider trading","Rule 10b5-1 trading plan","share sales","restricted stock units (RSUs)","weighted average price"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 Tradeweb Markets Inc. \u00b7 Filed 20260417","ticker":"TW","tickers":["TW"],"title":"TW filed 4","url":"https://www.sec.gov/Archives/edgar/data/1758730/0001758730-26-000090.txt"}...
|
NULL
|
NULL
|
NULL
|
NULL
|
discovery_sec_filings
|
{"_evidence_event_ids":["evt_5e3a9f20c {"_evidence_event_ids":["evt_5e3a9f20c18a"]}...
|
signal_enriched:discovery_sec_filing_delta:c2950d8 signal_enriched:discovery_sec_filing_delta:c2950d8b63c5b7c9...
|
0
|
2026-04-18T03:05:05.644967+00:00
|
Edit
Delete
|